Name,SMILES,hit_inh,hit_kill
triclosan,Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl,1.0,1.0
amiselimod,CCCCCCCOc1ccc(CCC(N)(CO)CO)cc1C(F)(F)F,1.0,1.0
silver-sulfadiazine,Nc1ccc(cc1)S(=O)(=O)N([Ag])c1ncccn1,1.0,1.0
visomitin,"CC1=C(C)C(=O)C(CCCCCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)=CC1=O |c:1,38|",1.0,1.0
colistin,"CC[C@@H](C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O |a:10,17,18,24,31,37,41,48,55,63,71,78,&1:2|",1.0,1.0
LTX-315,NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O,1.0,1.0
KHK-IN-1,CSc1ccccc1Nc1nc(nc2c(NCC3CC3)ncnc12)N1CCNCC1,0.0,1.0
stattic,[O-][N+](=O)c1ccc2C=CS(=O)(=O)c2c1 |c:7|,1.0,1.0
BAY-11-7082,Cc1ccc(cc1)S(=O)(=O)\C=C\C#N,1.0,1.0
AZ505,Oc1ccc(CCNCCN(C2CCCCC2)C(=O)CCNCCc2ccc(Cl)c(Cl)c2)c2OCC(=O)Nc12,0.0,1.0
levofloxacin,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O,1.0,1.0
gemifloxacin,CO\N=C1/CN(C[C@@H]1CN)c1nc2n(cc(C(O)=O)c(=O)c2cc1F)C1CC1 |&1:7|,1.0,0.0
sulopenem,"C[C@@H](O)[C@@H]1[C@H]2SC(S[C@H]3CC[S@@](=O)C3)=C(N2C1=O)C(O)=O |&1:11,c:14|",1.0,0.0
tebipenem,"C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(SC3CN(C3)C3=NCCS3)=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C |c:19,t:14|",1.0,0.0
cefmenoxime,[H][C@]12SCC(CSc3nnnn3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\c1csc(N)n1)C(O)=O |c:13|,1.0,0.0
orbifloxacin,C[C@H]1CN(C[C@@H](C)N1)c1c(F)c(F)c2c(c1F)n(cc(C(O)=O)c2=O)C1CC1,1.0,0.0
gamithromycin,[H][C@@]1(C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)O[C@H]1[C@H](C)[C@@H](O[C@]2([H])O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)N(CCC)C[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@@H]1C,1.0,0.0
lomefloxacin,CCn1cc(C(O)=O)c(=O)c2cc(F)c(N3CCN[C@@H](C)C3)c(F)c12 |&1:19|,1.0,0.0
rifabutin,"CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2C4=NC5(CCN(CC(C)C)CC5)NC4=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(=O)c2c(O)c3C |c:36,t:3,15,30,38|",1.0,0.0
piperacillin,CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)c2ccccc2)C(=O)C1=O,1.0,0.0
floxuridine,OC[C@H]1O[C@H](C[C@@H]1O)n1cc(F)c(=O)[nH]c1=O,1.0,0.0
nitrofurantoin,[O-][N+](=O)c1ccc(\C=N\N2CC(=O)NC2=O)o1,1.0,0.0
methacycline,"[H][C@]12[C@H](O)[C@@]3([H])[C@H](N(C)C)C(=O)[C@H](C(N)=O)C(=O)[C@@]3(O)C(=O)[C@H]1C(=O)c1c(O)cccc1C2=C |&1:22,&2:12|",1.0,0.0
minocycline,"[H][C@@]12Cc3c(ccc(O)c3C(=O)[C@@H]1C(=O)[C@]1(O)C(=O)[C@H](C(N)=O)C(=O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C |&1:19,&2:12|",1.0,0.0
diaveridine,COc1ccc(Cc2cnc(N)nc2N)cc1OC,1.0,0.0
cefixime,Nc1nc(cs1)C(=N\OCC(O)=O)\C(=O)N[C@H]1[C@H]2SCC(C=C)=C(N2C1=O)C(O)=O |c:23|,1.0,0.0
demeclocycline,"[H][C@]12C[C@@]3([H])[C@H](N(C)C)C(=O)[C@@H](C(N)=O)C(=O)[C@@]3(O)C(=O)[C@H]1C(=O)c1c(O)ccc(Cl)c1[C@H]2O |&1:11,&2:21|",1.0,0.0
Ro-3,COc1cc(Cc2cnc(N)nc2N)c(cc1OC)C(C)C,1.0,0.0
erythromycin,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,1.0,0.0
cefaclor,N[C@@H](C(=O)N[C@H]1[C@H]2SCC(Cl)=C(N2C1=O)C(O)=O)c1ccccc1 |c:10|,1.0,0.0
cefodizime,CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(CSc3nc(C)c(CC(O)=O)s3)=C(N2C1=O)C(O)=O)c1csc(N)n1 |c:24|,1.0,0.0
auranofin,CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O,1.0,0.0
amodiaquine,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,1.0,0.0
enoxacin,CCn1cc(C(O)=O)c(=O)c2cc(F)c(nc12)N1CCNCC1,1.0,0.0
hydroquinone,Oc1ccc(O)cc1,0.0,0.0
2-methyl-5-nitrophenol,Cc1ccc(cc1O)[N+]([O-])=O,0.0,0.0
cimetidine,CN\C(NCCSCc1[nH]cnc1C)=N/C#N,0.0,0.0
NN-DNJ,CCCCCCCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,0.0,0.0
vecuronium,CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)N1CCCCC1)[N+]1(C)CCCCC1,0.0,0.0
LY411575,C[C@H](NC(=O)[C@@H](O)c1cc(F)cc(F)c1)C(=O)N[C@H]1c2ccccc2-c2ccccc2N(C)C1=O,0.0,0.0
FGIN-1-27,CCCCCCN(CCCCCC)C(=O)Cc1c([nH]c2ccccc12)-c1ccc(F)cc1,0.0,0.0
allopurinol-riboside,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ncc2c(O)ncnc12,0.0,0.0
AC-710,CCN1C(C)(C)CC(CC1(C)C)Oc1ccc(nc1)C(=O)Nc1ccc(NC(=O)Nc2cc(on2)C(C)(C)C)cc1,0.0,0.0
bisphenol-A,CC(C)(c1ccc(O)cc1)c1ccc(O)cc1,0.0,0.0
ephedrine,CN[C@@H](C)[C@H](O)c1ccccc1,0.0,0.0
cenobamate,NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl,0.0,0.0
deoxyarbutin,"Oc1ccc(O[C@H]2CCCCO2)cc1 |&1:6,r|",0.0,0.0
hexamethonium,C[N+](C)(C)CCCCCC[N+](C)(C)C,0.0,0.0
NVS-PAK1-1,CC(C)NC(=O)N1CC[C@@H](C1)NC1=Nc2cc(F)ccc2N(CC(F)F)c2ccc(Cl)cc12 |t:13|,0.0,0.0
propylene-glycol,"C[C@@H](O)CO |&1:1,r|",0.0,0.0
astragaloside-a,CC(C)(O)[C@H]1CC[C@](C)(O1)[C@H]1[C@@H](O)C[C@@]2(C)[C@@H]3C[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H]4[C@]5(C[C@@]35CC[C@]12C)CC[C@H](O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O)C4(C)C,0.0,0.0
PP-121,Nc1ncnc2n(nc(-c3cnc4[nH]ccc4c3)c12)C1CCCC1,0.0,0.0
tavaborole,OB1OCc2cc(F)ccc12,0.0,0.0
RG7834,COCCCOc1cc2C[C@@H](C(C)C)n3cc(C(O)=O)c(=O)cc3-c2cc1OC,0.0,0.0
amthamine,Cc1nc(N)sc1CCN,0.0,0.0
ditolylguanidine,Cc1ccccc1NC(=N)Nc1ccccc1C,0.0,0.0
GM-1485,CCC(C)(C)C(=O)C(=O)N1CCC[C@H]1C(O)=O,0.0,0.0
RS-67333,CCCCN1CCC(CCC(=O)c2cc(Cl)c(N)cc2OC)CC1,0.0,0.0
NMS-1286937,CN1CCN(CC1)c1ccc(OC(F)(F)F)c(Nc2ncc3CCc4c(nn(CCO)c4-c3n2)C(N)=O)c1,0.0,0.0
GNF-2,NC(=O)c1cccc(c1)-c1cc(Nc2ccc(OC(F)(F)F)cc2)ncn1,0.0,0.0
adoprazine,Fc1ccc(cc1)-c1cncc(CN2CCN(CC2)c2cccc3OCCOc23)c1,0.0,0.0
indoramin,O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1,0.0,0.0
olomoucine,Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12,0.0,0.0
SB-200646,Cn1ccc2cc(NC(=O)Nc3cccnc3)ccc12,0.0,0.0
proquazone,CC(C)n1c2cc(C)ccc2c(nc1=O)-c1ccccc1,0.0,0.0
ambroxol,Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1 |r|,0.0,0.0
levocabastine,C[C@@H]1CN(CC[C@]1(C(O)=O)c1ccccc1)[C@H]1CC[C@](CC1)(C#N)c1ccc(F)cc1,0.0,0.0
methylparaben,COC(=O)c1ccc(O)cc1,0.0,0.0
PD-156707,COc1ccc(cc1)C(=O)C(\Cc1cc(OC)c(OC)c(OC)c1)=C(/C(O)=O)c1ccc2OCOc2c1,0.0,0.0
V-51,COc1cc(CN2CCN(CC2)c2ccc(F)cc2)cc(OC)c1OC,0.0,0.0
deptropine,"CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC1c2ccccc2CCc2ccccc12 |r,THB:0:1:3.4:6.7.8|",0.0,0.0
nepafenac,NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N,0.0,0.0
ivabradine,COc1cc2C[C@H](CN(C)CCCN3CCc4cc(OC)c(OC)cc4CC3=O)c2cc1OC,0.0,0.0
L-asparagine,N[C@@H](CC(N)=O)C(O)=O,0.0,0.0
VE-821,CS(=O)(=O)c1ccc(cc1)-c1cnc(N)c(n1)C(=O)Nc1ccccc1,0.0,0.0
urea,NC(N)=O,0.0,0.0
methimazole,Cn1cc[nH]c1=S,0.0,0.0
benperidol,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O,0.0,0.0
GSK-J4,CCOC(=O)CCNc1cc(nc(n1)-c1ccccn1)N1CCc2ccccc2CC1,0.0,0.0
phenothrin,"CC(C)=C[C@H]1[C@@H](C(=O)OCc2cccc(Oc3ccccc3)c2)C1(C)C |&1:4,&2:5,r|",0.0,0.0
veliparib,C[C@@]1(CCCN1)c1nc2cccc(C(N)=O)c2[nH]1,0.0,0.0
L-161982,CCCCc1nn(-c2ccccc2C(F)(F)F)c(=O)n1Cc1ccc(cc1)-c1ccccc1S(=O)(=O)NC(=O)c1sccc1C,0.0,0.0
PQ-401,COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12,0.0,0.0
BX-912,Brc1cnc(Nc2cccc(NC(=O)N3CCCC3)c2)nc1NCCc1cnc[nH]1,0.0,0.0
cantharidin,C[C@]12[C@@H]3CC[C@@H](O3)[C@@]1(C)C(=O)OC2=O,0.0,0.0
ebastine,CC(C)(C)c1ccc(cc1)C(=O)CCCN1CCC(CC1)OC(c1ccccc1)c1ccccc1,0.0,0.0
8-hydroxy-PIPAT,CCCN(C\C=C\I)[C@H]1CCc2cccc(O)c2C1 |&1:8|,0.0,0.0
cytisine,O=c1cccc2[C@H]3CNC[C@H](C3)Cn12,0.0,0.0
TUG-891,Cc1ccc(cc1)-c1ccc(F)cc1COc1ccc(CCC(O)=O)cc1,0.0,0.0
dasabuvir,COc1c(cc(cc1C(C)(C)C)-n1ccc(=O)[nH]c1=O)-c1ccc2cc(NS(C)(=O)=O)ccc2c1,0.0,0.0
OSI-420,COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCO,0.0,0.0
dabigatran,Cn1c(CNc2ccc(cc2)C(N)=N)nc2cc(ccc12)C(=O)N(CCC(O)=O)c1ccccn1,0.0,0.0
tazobactam,C[C@]1(Cn2ccnn2)[C@@H](N2[C@@H](CC2=O)S1(=O)=O)C(O)=O,0.0,0.0
CPP,OC(=O)[C@H]1CN(CCCP(O)(O)=O)CCN1,0.0,0.0
iopanic-acid,"CC[C@@H](Cc1c(I)cc(I)c(N)c1I)C(O)=O |&1:2,r|",0.0,0.0
nimustine,Cc1ncc(CNC(=O)N(CCCl)[NH2+][O-])c(N)n1,0.0,0.0
GSK2256294A,CNc1nc(C)nc(N[C@H]2CCC[C@H](C2)C(=O)NCc2ccc(cc2C(F)(F)F)C#N)n1,0.0,0.0
PTC-028,Cc1nc2cc(F)c(F)cc2n1-c1cncc(Nc2ccc(cc2)C(F)(F)F)n1,0.0,0.0
CCT-031374,O=C(CN1C2=NCCN2c2ccccc12)c1ccc(cc1)-c1ccccc1 |t:4|,0.0,0.0
acamprosate,CC(=O)NCCCS(O)(=O)=O,0.0,0.0
KRCA-0008,COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccc(cc2OC)N2CCN(CC2)C(C)=O)n1)N1CCN(CC1)C(C)=O,0.0,0.0
ANR-94,CCOc1nc2c(N)ncnc2n1CC,0.0,0.0
KB-R7943,NC(=N)SCCc1ccc(OCc2ccc(cc2)[N+]([O-])=O)cc1,0.0,0.0
L-ascorbyl-6-palmitate,"CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(=O)[C@@H]1O |a:19,21,&1:27|",0.0,0.0
BW-B70C,"C[C@@H](\C=C\c1cccc(Oc2ccc(F)cc2)c1)N(O)C(N)=O |&1:1,r|",0.0,0.0
bucillamine,CC(C)(S)C(=O)N[C@@H](CS)C(O)=O,0.0,0.0
IEM1754,NCCCCCNCC12CC3CC(CC(C3)C1)C2,0.0,0.0
harringtonine,[H][C@@]12[C@H](OC(=O)[C@@](O)(CCC(C)(C)O)CC(=O)OC)C(OC)=C[C@@]11CCCN1CCc1cc3OCOc3cc21 |c:21|,0.0,0.0
hydroxypropyl-beta-cyclodextrin,"C[C@@H](O)COC[C@H]1O[C@@H]2O[C@@H]3[C@@H](COC[C@@H](C)O)O[C@H](O[C@@H]4[C@@H](COC[C@@H](C)O)O[C@H](O[C@@H]5[C@@H](COC[C@@H](C)O)O[C@H](O[C@@H]6[C@@H](COC[C@@H](C)O)O[C@H](O[C@@H]7[C@@H](COC[C@@H](C)O)O[C@H](O[C@@H]8[C@@H](COC[C@@H](C)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O |a:6,8,10,11,19,21,22,30,32,33,41,43,44,52,54,55,63,65,66,74,76,77,79,81,83,85,87,89,91,93,95,97,99,101,103,&1:1,&2:15,&3:26,&4:37,&5:48,&6:59,&7:70|",0.0,0.0
trandolapril,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@@H]2C[C@H]1C(O)=O,0.0,0.0
4-CMTB,"CC(C)[C@@H](C(=O)Nc1nccs1)c1ccc(Cl)cc1 |&1:3,r|",0.0,0.0
nalfurafine,CN([C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CC1)c45)C(=O)\C=C\c1ccoc1,0.0,0.0
PP-2,CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc12,0.0,0.0
cypermethrin,"CC1(C)[C@@H](C=C(Cl)Cl)[C@@H]1C(=O)O[C@@H](C#N)c1cccc(Oc2ccccc2)c1 |&1:3,&2:8,&3:12,r|",0.0,0.0
LY255283,CCc1cc(C(C)=O)c(O)cc1OCCCCCC(C)(C)c1nn[nH]n1,0.0,0.0
GW-501516,Cc1nc(sc1CSc1ccc(OCC(O)=O)c(C)c1)-c1ccc(cc1)C(F)(F)F,0.0,0.0
diacetamate,CC(=O)Nc1ccc(OC(C)=O)cc1,0.0,0.0
bumetanide,CCCCNc1cc(cc(c1Oc1ccccc1)S(N)(=O)=O)C(O)=O,0.0,0.0
omega-(4-iodophenyl)pentadecanoic-acid,OC(=O)CCCCCCCCCCCCCCc1ccc(I)cc1,0.0,0.0
nelociguat,COC(=O)Nc1c(N)nc(nc1N)-c1nn(Cc2ccccc2F)c2ncccc12,0.0,0.0
D-delta-tocopherol,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2cc(O)cc(C)c2O1,0.0,0.0
exo-IWR-1,O=C(Nc1cccc2cccnc12)c1ccc(cc1)N1C(=O)[C@H]2[C@H]3C[C@H](C=C3)[C@H]2C1=O |c:29|,0.0,0.0
fenbendazole,COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1,0.0,0.0
flutamide,CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+]([O-])=O,0.0,0.0
acetriazoic-acid,CC(=O)Nc1c(I)cc(I)c(C(O)=O)c1I,0.0,0.0
elvitegravir,COc1cc2n(cc(C(O)=O)c(=O)c2cc1Cc1cccc(Cl)c1F)[C@H](CO)C(C)C,0.0,0.0
TC-OT-39,CN1CCCN(CC1)C(=S)[C@@H]1CCCN1C(=O)NCc1ccc(cc1C)C(=O)N1Cc2cnn(C)c2Nc2ccccc12,0.0,0.0
E3330,"CCCCCCCCC\C(=C/C1=C(C)C(=O)C(OC)=C(OC)C1=O)C(O)=O |c:11,t:18|",0.0,0.0
sulfanitran,CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)[N+]([O-])=O,0.0,0.0
OLDA,CCCCCCCC\C=C/CCCCCCCC(=O)NCCc1ccc(O)c(O)c1,0.0,0.0
SR-2640,OC(=O)c1ccccc1Nc1cccc(OCc2ccc3ccccc3n2)c1,0.0,0.0
SD-2590,COCCN1CCC(CC1)(C(=O)NO)S(=O)(=O)c1ccc(Oc2ccc(OC(F)(F)F)cc2)cc1,0.0,0.0
histamine,NCCc1cnc[nH]1,0.0,0.0
amantadine,NC12CC3CC(CC(C3)C1)C2,0.0,0.0
LY3000328,CNC(=O)O[C@H]1COc2ccc(cc2[C@@H]1NC(=O)c1ccc(F)cc1)N1CCN(CC1)C1COC1,0.0,0.0
propatylnitrate,CCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O,0.0,0.0
CZC24832,CC(C)(C)NS(=O)(=O)c1cncc(c1)-c1cc(F)c2nc(N)nn2c1,0.0,0.0
VT-464,CC(C)[C@@](O)(c1cn[nH]n1)c1ccc2cc(OC(F)F)c(OC(F)F)cc2c1,0.0,0.0
CCMQ,OC(=O)Cc1cc2ccccc2nc1C(O)=O,0.0,0.0
BRL-54443,CN1CCC(CC1)c1c[nH]c2ccc(O)cc12,0.0,0.0
piclamilast,COc1ccc(cc1OC1CCCC1)C(=O)Nc1c(Cl)cncc1Cl,0.0,0.0
oleoylethanolamide,CCCCCCCC\C=C/CCCCCCCC(=O)NCCO,0.0,0.0
phloroglucin,Oc1cc(O)cc(O)c1,0.0,0.0
ravuconazole,C[C@@H](c1nc(cs1)-c1ccc(cc1)C#N)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,0.0,0.0
bromopride,CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC,0.0,0.0
naloxone,Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O,0.0,0.0
streptozotocin,CN([NH2+][O-])C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O,0.0,0.0
FK-3311,CC(=O)c1ccc(NS(C)(=O)=O)c(Oc2ccc(F)cc2F)c1,0.0,0.0
GW-542573X,COc1ccccc1NC(=O)OCC1CCN(CC1)C(=O)OC(C)(C)C,0.0,0.0
L-cysteine,N[C@@H](CS)C(O)=O,0.0,0.0
squaric-acid-dibutyl-ester,CCCCOc1c(OCCCC)c(=O)c1=O,0.0,0.0
ASA-404,Cc1ccc2c(oc3c(CC(O)=O)cccc3c2=O)c1C,0.0,0.0
VCH-916,"CO[C@H]1CC[C@@H](CC1)N(C(=O)[C@H]1CC[C@H](C)CC1)c1cc(sc1C(O)=O)C1=CCCCC1 |r,t:29|",0.0,0.0
GNTI,NC(=N)Nc1ccc2[nH]c3[C@@H]4Oc5c6c(C[C@H]7N(CC8CC8)CC[C@@]46[C@@]7(O)Cc3c2c1)ccc5O,0.0,0.0
acitazanolast,OC(=O)C(=O)Nc1cccc(c1)-c1nn[nH]n1,0.0,0.0
NVP-AEW541,Nc1ncnc2n(cc(-c3cccc(OCc4ccccc4)c3)c12)[C@@H]1C[C@H](CN2CCC2)C1 |r|,0.0,0.0
ML179,FC(F)(F)c1cccc(c1)N1CCN(CC1)c1cc(=O)n(C2CCCCC2)c(=O)[nH]1,0.0,0.0
CI-923,"CCN[C@@H](C)CN1CCc2c(C1)c(=O)oc1ccccc21 |&1:3,r|",0.0,0.0
pyrazolanthrone,O=C1c2ccccc2-c2[nH]nc3cccc1c23,0.0,0.0
BGP-15,"O[C@H](CONC(=N)c1cccnc1)CN1CCCCC1 |&1:1,r|",0.0,0.0
mestinon,CN(C)C(=O)Oc1ccc[n+](C)c1,0.0,0.0
ZD-7114,COCCNC(=O)COc1ccc(OCCNC[C@H](O)COc2ccccc2)cc1,0.0,0.0
PI-103,Oc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1,0.0,0.0
1-octacosanol,CCCCCCCCCCCCCCCCCCCCCCCCCCCCO,0.0,0.0
CC-90003,COc1cc(Nc2ncc(c(Nc3ccc(C)cc3NC(=O)C=C)n2)C(F)(F)F)c(C)cn1,0.0,0.0
antagonist-g,CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,0.0,0.0
efavirenz,FC(F)(F)[C@]1(OC(=O)Nc2ccc(Cl)cc12)C#CC1CC1,0.0,0.0
bacitracin,CC[C@H](C)[C@H](N)C1=N[C@@H](CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)[C@@H](C)CC |t:6|,0.0,0.0
mecysteine,COC(=O)[C@@H](N)CS,0.0,0.0
3-deazaneplanocin-A,Nc1nccc2n(cnc12)[C@@H]1C=C(CO)[C@@H](O)[C@H]1O |t:13|,0.0,0.0
leuprolide,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1,0.0,0.0
ractopamine,"C[C@@H](CCc1ccc(O)cc1)NC[C@@H](O)c1ccc(O)cc1 |&1:1,&2:13,r|",0.0,0.0
CCG-50014,Cc1ccc(cc1)-n1sc(=O)n(Cc2ccc(F)cc2)c1=O,0.0,0.0
defactinib,CNC(=O)c1ccc(Nc2ncc(c(NCc3nccnc3N(C)S(C)(=O)=O)n2)C(F)(F)F)cc1,0.0,0.0
rebastinib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1,0.0,0.0
lovastatin,"CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 |c:13,t:11|",0.0,0.0
L-citrulline,"N[C@@H](CCCNC(N)=O)C(O)=O |&1:1,r|",0.0,0.0
7-hydroxy-DPAT,CCCN(CCC)[C@H]1CCc2ccc(O)cc2C1 |&1:7|,0.0,0.0
PhiKan-083,CCn1c2ccccc2c2cc(CNC)ccc12,0.0,0.0
AZD9668,Cc1c(cc(C(=O)NCc2ccc(cn2)S(C)(=O)=O)c(=O)n1-c1cccc(c1)C(F)(F)F)-c1ccnn1C,0.0,0.0
tolmetin,Cc1ccc(cc1)C(=O)c1ccc(CC(O)=O)n1C,0.0,0.0
AS-2034178,OC(=O)CCc1ccc(NCc2cccc3N(CCOc4ccccc4)CCCc23)cc1F,0.0,0.0
triciribine-phosphate,Cn1nc(N)c2cn([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)c3ncnc1c23,0.0,0.0
droloxifene,CC\C(=C(\c1ccc(OCCN(C)C)cc1)c1cccc(O)c1)c1ccccc1,0.0,0.0
sumatriptan,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,0.0,0.0
digitoxigenin,C[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@@H]2C1=CC(=O)OC1 |t:25|,0.0,0.0
esaprazole,O=C(CN1CCNCC1)NC1CCCCC1,0.0,0.0
cilazapril,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@H](N2C1=O)C(O)=O,0.0,0.0
puromycin,COc1ccc(C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)n2cnc3c(ncnc23)N(C)C)cc1,0.0,0.0
lurasidone,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(CC1)c1nsc2ccccc12,0.0,0.0
NBI-27914,CCCN(CC1CC1)c1nc(C)nc(Nc2c(Cl)cc(Cl)cc2Cl)c1Cl,0.0,0.0
flunarizine,Fc1ccc(cc1)C(N1CCN(C\C=C\c2ccccc2)CC1)c1ccc(F)cc1,0.0,0.0
talarozole,"CCC(CC)[C@@H](c1ccc(Nc2nc3ccccc3s2)cc1)n1cncn1 |&1:5,r|",0.0,0.0
trichlormethiazide,"NS(=O)(=O)c1cc2c(N[C@@H](NS2(=O)=O)C(Cl)Cl)cc1Cl |&1:9,r|",0.0,0.0
galeterone,"[H][C@@]12CC=C(n3cnc4ccccc34)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C |t:3,27|",0.0,0.0
cefamandole,Cn1nnnc1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](O)c1ccccc1)C2=O)C(O)=O |t:9|,0.0,0.0
adiphenine,CCN(CC)CCOC(=O)C(c1ccccc1)c1ccccc1,0.0,0.0
chloroquine,CCN(CC)CCC[C@@H](C)Nc1ccnc2cc(Cl)ccc12 |&1:8|,0.0,0.0
rivaroxaban,Clc1ccc(s1)C(=O)NC[C@H]1CN(C(=O)O1)c1ccc(cc1)N1CCOCC1=O,0.0,0.0
acumapimod,Cc1ccc(cc1-n1ncc(C(=O)c2cccc(c2)C#N)c1N)C(=O)NC1CC1,0.0,0.0
paquinimod,CCN(C(=O)c1c(O)c2c(CC)cccc2n(C)c1=O)c1ccccc1,0.0,0.0
ML133,COc1ccc(CNCc2cccc3ccccc23)cc1,0.0,0.0
bopindolol,Cc1cc2c(OC[C@@H](CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 |&1:7|,0.0,0.0
ML218,CC(C)(C)CCN1C[C@H]2[C@H](CNC(=O)c3cc(Cl)cc(Cl)c3)[C@H]2C1,0.0,0.0
indeloxazine,"C(Oc1cccc2C=CCc12)[C@H]1CNCCO1 |&1:11,c:7|",0.0,0.0
YM-511,Brc1ccc(CN(c2ccc(cc2)C#N)n2cnnc2)cc1,0.0,0.0
adenosine,Nc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,0.0,0.0
SC-12267,COc1cccc(c1)-c1ccc(NC(=O)C2=C(CCC2)C(O)=O)c(F)c1 |t:16|,0.0,0.0
ursodeoxycholyltaurine,C[C@H](CCC(=O)NCCS(O)(=O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C,0.0,0.0
etazolate,CCOC(=O)c1cnc2n(CC)ncc2c1NN=C(C)C,0.0,0.0
talnetant,CC[C@H](NC(=O)c1c(O)c(nc2ccccc12)-c1ccccc1)c1ccccc1,0.0,0.0
triflusal,CC(=O)Oc1cc(ccc1C(O)=O)C(F)(F)F,0.0,0.0
AMG-487,CCOc1ccc(cc1)-n1c(nc2ncccc2c1=O)[C@@H](C)N(Cc1cccnc1)C(=O)Cc1ccc(OC(F)(F)F)cc1,0.0,0.0
isofloxythepin,"CC(C)c1ccc2Sc3cc(F)ccc3C[C@@H](N3CCN(CCO)CC3)c2c1 |&1:16,r|",0.0,0.0
secalciferol,C[C@H](CC[C@@H](O)C(C)(C)O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,0.0,0.0
PD-168568,Cc1ccc(cc1C)N1CCN(CC[C@H]2NC(=O)c3ccccc23)CC1 |&1:14|,0.0,0.0
chlorfenson,Clc1ccc(OS(=O)(=O)c2ccc(Cl)cc2)cc1,0.0,0.0
idazoxan,"C1CN=C(N1)[C@H]1COc2ccccc2O1 |r,c:2|",0.0,0.0
g-caryophyllene,C\C1=C/CCC(=C)[C@H]2CC(C)(C)[C@@H]2CC1 |c:1|,0.0,0.0
FK-962,CC(=O)N1CCC(CC1)NC(=O)c1ccc(F)cc1,0.0,0.0
salicylanilide,Oc1ccccc1C(=O)Nc1ccccc1,0.0,0.0
oprozomib,COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc1ccccc1)C(=O)[C@@]1(C)CO1,0.0,0.0
octreotide,"C[C@@H](O)[C@@H](CO)NC(=O)[C@H]1CSSC[C@@H](NC(=O)[C@@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 |&1:1,&2:3,&3:9,&4:14,&5:18,&6:30,&7:41,&8:55,&9:64,&10:65|",0.0,0.0
JNJ-64619178,Nc1nc2cc(CC[C@H]3C[C@H]([C@H](O)[C@@H]3O)n3ccc4c(N)ncnc34)ccc2cc1Br,0.0,0.0
VX-745,Fc1ccc(Sc2ccc3c(-c4c(Cl)cccc4Cl)c(=O)ncn3n2)c(F)c1,0.0,0.0
tipelukast,CCCc1c(O)c(ccc1SCCCOc1ccc(C(C)=O)c(OCCCC(O)=O)c1CCC)C(C)=O,0.0,0.0
CNX-2006,COc1cc(NC2CN(CCF)C2)ccc1Nc1ncc(c(Nc2cccc(NC(=O)C=C)c2)n1)C(F)(F)F,0.0,0.0
lazabemide,NCCNC(=O)c1ccc(Cl)cn1,0.0,0.0
TCS-5861528,"CC[C@@H](C)c1ccc(NC(=O)Cn2cnc3n(C)c(=O)n(C)c(=O)c23)cc1 |&1:2,r|",0.0,0.0
riboflavin,Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C[C@H](O)[C@H](O)[C@H](O)CO)c2cc1C,0.0,0.0
taurolidine,O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1,0.0,0.0
brigatinib,COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1)N1CCC(CC1)N1CCN(C)CC1,0.0,0.0
1-ethyl-2-pyrrolidone,CCN1CCCC1=O,0.0,0.0
MI-14,CN(C)S(=O)(=O)c1cccc(c1)-c1c(C)nc2c(NCCNC(C)=O)cc(Cl)nn12,0.0,0.0
terconazole,CC(C)N1CCN(CC1)c1ccc(OC[C@H]2CO[C@@](Cn3cncn3)(O2)c2ccc(Cl)cc2Cl)cc1,0.0,0.0
EW-7197,Cc1cccc(n1)-c1nc(CNc2ccccc2F)[nH]c1-c1ccc2ncnn2c1,0.0,0.0
KP-1212,NC1=NC(=O)N(CN1)[C@H]1C[C@@H](O)[C@@H](CO)O1 |t:1|,0.0,0.0
transcrocetinate,C\C(\C=C\C=C(/C)C(O)=O)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O,0.0,0.0
dantron,Oc1cccc2C(=O)c3cccc(O)c3C(=O)c12,0.0,0.0
pritelivir,CN(C(=O)Cc1ccc(cc1)-c1ccccn1)c1nc(C)c(s1)S(N)(=O)=O,0.0,0.0
SR-33805,COc1ccc(CCN(C)CCCOc2ccc(cc2)S(=O)(=O)c2c(C(C)C)c3ccccc3n2C)cc1OC,0.0,0.0
alanosine,N[C@@H](CN(O)[N+][O-])C(O)=O,0.0,0.0
fulvestrant,"C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCC[S@@](=O)CCCC(F)(F)C(F)(F)F)Cc1cc(O)ccc31 |a:1,4,5,6,9,11,&1:21|",0.0,0.0
SCH-221510,"Cc1ccccc1C(N1[C@H]2CC[C@@H]1C[C@](O)(C2)c1ccccc1)c1ccccc1C |&1:9,12,14,r|",0.0,0.0
DY131,CCN(CC)c1ccc(\C=N\NC(=O)c2ccc(O)cc2)cc1,0.0,0.0
NGB-2904,Clc1cccc(N2CCN(CCCCNC(=O)c3ccc-4c(Cc5ccccc-45)c3)CC2)c1Cl,0.0,0.0
TC-H-106,Cc1ccc(NC(=O)CCCCCC(=O)Nc2ccccc2N)cc1,0.0,0.0
amineptine,OC(=O)CCCCCCNC1c2ccccc2CCc2ccccc12,0.0,0.0
netilmicin,[H][C@]1(O[C@@H]2[C@@H](N)C[C@@H](NCC)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)OC(CN)=CC[C@H]1N |c:32|,0.0,0.0
N-alpha-methylhistamine-dihydrochloride,CNCCc1cnc[nH]1,0.0,0.0
N-MPPP,CN([C@H](CN1CCCC1)c1ccccc1)C(=O)Cc1ccccc1,0.0,0.0
XL888,[H][C@]1(C[C@@H]2CC[C@H](C1)N2c1ccc(cn1)C(=O)C1CC1)NC(=O)c1cc(N[C@H](C)CC)c(cc1C)C(N)=O |TLB:9:8:4.5:1.2.7|,0.0,0.0
sangivamycin,NC(=O)c1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12,0.0,0.0
EUK-134,"COc1cccc2C=[N+]3CC[N+]4=Cc5cccc(OC)c5O[Mn]34(Cl)Oc12 |t:7,11|",0.0,0.0
MDMS,CS(=O)(=O)OCOS(C)(=O)=O,0.0,0.0
PRT062607,N[C@H]1CCCC[C@H]1Nc1ncc(C(N)=O)c(Nc2cccc(c2)-n2nccn2)n1,0.0,0.0
carteolol,CC(C)(C)NCC(O)COc1cccc2NC(=O)CCc12,0.0,0.0
BAY-2402234,CCn1c(CO)nn(-c2cc(O[C@@H](C)C(F)(F)F)c(cc2F)C(=O)Nc2c(F)cccc2Cl)c1=O,0.0,0.0
API-001,Cc1cc(OCCN2CCOCC2)nn1-c1ccc2ccccc2c1,0.0,0.0
fendiline,C[C@@H](NCCC(c1ccccc1)c1ccccc1)c1ccccc1 |&1:1|,0.0,0.0
AZD4573,CC(=O)N[C@@H]1CCC[C@@H](C1)C(=O)Nc1cc(-c2cnn3CC(C)(C)Cc23)c(Cl)cn1,0.0,0.0
bicuculline-(+),CN1CCc2cc3OCOc3cc2[C@H]1[C@@H]1OC(=O)c2c1ccc1OCOc21,0.0,0.0
fostamatinib,COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)N(COP(O)(O)=O)c4n3)n2)cc(OC)c1OC,0.0,0.0
tremorine,C(C#CCN1CCCC1)N1CCCC1,0.0,0.0
tranexamic-acid,NC[C@H]1CC[C@@H](CC1)C(O)=O |r|,0.0,0.0
GS-143,OC(=O)c1ccc(cc1)N1N=C(Cc2ccccc2)\C(=C/c2ccc(o2)-c2ccccc2F)C1=O |t:11|,0.0,0.0
hetacillin,CC1(C)S[C@@H]2[C@H](N3C(=O)[C@H](NC3(C)C)c3ccccc3)C(=O)N2[C@H]1C(O)=O,0.0,0.0
amlodipine,"CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1c1ccccc1Cl)C(=O)OC |&1:16,r,c:5,14|",0.0,0.0
tecovirimat,FC(F)(F)c1ccc(cc1)C(=O)NN1C(=O)[C@H]2[C@H]([C@H]3C=C[C@@H]2[C@@H]2C[C@H]32)C1=O |c:20|,0.0,0.0
4E1RCat,OC(=O)c1ccc(cc1)N1C(=O)\C(=C\c2ccc(o2)-c2ccc(cc2)[N+]([O-])=O)C=C1c1ccccc1 |c:31|,0.0,0.0
SKA-31,Nc1nc2c(ccc3ccccc23)s1,0.0,0.0
azimilide,CN1CCN(CCCCN2C(=O)CN(\N=C\c3ccc(o3)-c3ccc(Cl)cc3)C2=O)CC1,0.0,0.0
udenafil,"CCCOc1ccc(cc1-c1nc2c(CCC)nn(C)c2c(=O)[nH]1)S(=O)(=O)NCC[C@@H]1CCCN1C |&1:30,r|",0.0,0.0
denotivir,Cc1nsc(NC(=O)c2ccccc2)c1C(=O)Nc1ccc(Cl)cc1,0.0,0.0
LIMKi-3,CC(C)C(=O)Nc1ncc(s1)-c1cc(nn1-c1c(Cl)cccc1Cl)C(F)F,0.0,0.0
atropine,"CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@@H](CO)c1ccccc1 |a:2,5,7,&1:12,THB:9:7:1:3.4|",0.0,0.0
cotinine,CN1[C@@H](CCC1=O)c1cccnc1,0.0,0.0
"5-(4chlorophenyl)-4-ethyl-2,4-dihydro-3H-1,2,4-triazol-3-one",CCn1c(n[nH]c1=O)-c1ccc(Cl)cc1,0.0,0.0
opicapone,Cc1c(Cl)c(C)[n+]([O-])c(Cl)c1-c1noc(n1)-c1cc(O)c(O)c(c1)[N+]([O-])=O,0.0,0.0
AM-92016,CN(CCc1ccc(Cl)c(Cl)c1)C[C@@H](O)COc1ccc(NS(C)(=O)=O)cc1 |&1:13|,0.0,0.0
bavisant,O=C(N1CCN(CC1)C1CC1)c1ccc(CN2CCOCC2)cc1,0.0,0.0
PKI-166,C[C@@H](Nc1ncnc2[nH]c(cc12)-c1ccc(O)cc1)c1ccccc1,0.0,0.0
dimethisoquin,CCCCc1cc2ccccc2c(OCCN(C)C)n1,0.0,0.0
L-mimosine,N[C@@H](CN1CC(=O)C(=O)C=C1)C(O)=O |c:9|,0.0,0.0
tanshinone-IIA,Cc1coc-2c1C(=O)C(=O)c1c3CCCC(C)(C)c3ccc-21,0.0,0.0
CH223191,Cc1ccccc1\N=N\c1ccc(NC(=O)c2ccnn2C)c(C)c1,0.0,0.0
UNC0737,COc1cc2c(nc(nc2cc1OCCCN1CCCC1)C1CCCCC1)N(C)C1CCN(CC1)C(C)C,0.0,0.0
epothilone-A,C[C@H]1CCC[C@H]2O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\c1csc(C)n1,0.0,0.0
PSB-11,CC[C@@H]1CN2C(=N1)c1nc([nH]c1N(C)C2=O)-c1ccccc1 |c:5|,0.0,0.0
lifirafenib,FC(F)(F)c1ccc2nc([nH]c2c1)[C@@H]1[C@H]2Oc3ccc(Oc4ccnc5NC(=O)CCc45)cc3[C@@H]12,0.0,0.0
prednisolone,"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO |a:1,3,15,20,&1:5,&2:6,&3:17,c:13,t:9|",0.0,0.0
bemegride,CCC1(C)CC(=O)NC(=O)C1,0.0,0.0
M-344,CN(C)c1ccc(cc1)C(=O)NCCCCCCC(=O)NO,0.0,0.0
istradefylline,CCn1c2nc(\C=C\c3ccc(OC)c(OC)c3)n(C)c2c(=O)n(CC)c1=O,0.0,0.0
tanespimycin,"CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O |c:7,23,t:15,21,34|",0.0,0.0
latrepirdine,CN1CCc2c(C1)c1cc(C)ccc1n2CCc1ccc(C)nc1,0.0,0.0
sclareol,"CC(O)(CC[C@H]1[C@](C)(O)CC[C@H]2C(C)(C)CCC[C@]12C)C=C |a:5,6,18,&1:1,&2:11|",0.0,0.0
buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1,0.0,0.0
netupitant,CN(C(=O)C(C)(C)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)c1cnc(cc1-c1ccccc1C)N1CCN(C)CC1,0.0,0.0
GW-4064,CC(C)c1onc(c1COc1ccc(\C=C\c2cccc(c2)C(O)=O)c(Cl)c1)-c1c(Cl)cccc1Cl,0.0,0.0
tigecycline,"[H][C@@]12Cc3c(cc(NC(=O)CNC(C)(C)C)c(O)c3C(=O)[C@@H]1C(=O)[C@]1(O)C(=O)[C@H](C(N)=O)C(=O)[C@@H](N(C)C)[C@]1([H])C2)N(C)C |&1:28,&2:21|",0.0,0.0
rolitetracycline,"CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)[C@]2(O)C(O)=C(C(=O)NCN2CCCC2)C1=O)C(=O)c1c(O)cccc1[C@@]3(C)O |a:3,4,6,10,35,&1:7,&2:14,t:7,14|",0.0,0.0
CY208-243,CN1Cc2ccccc2[C@H]2[C@H]1Cc1c[nH]c3cccc2c13,0.0,0.0
tauroglycocholate,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCC(=O)NCCS(O)(=O)=O,0.0,0.0
dibekacin,NC[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)O1,0.0,0.0
bindarit,CC(C)(OCc1nn(Cc2ccccc2)c2ccccc12)C(O)=O,0.0,0.0
nemazoline,Nc1c(Cl)cc(C=C2NCCN2)cc1Cl,0.0,0.0
KML29,OC(C1CCN(CC1)C(=O)OC(C(F)(F)F)C(F)(F)F)(c1ccc2OCOc2c1)c1ccc2OCOc2c1,0.0,0.0
halothane,"FC(F)(F)[C@@H](Cl)Br |&1:4,r|",0.0,0.0
estradiol,C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O,0.0,0.0
isavuconazole,"C[C@@H](c1nc(cs1)-c1ccc(cc1)C#N)[C@@](O)(Cn1cncn1)c1cc(F)ccc1F |a:1,&1:15|",0.0,0.0
BAY1125976,NC(=O)c1ccc2nc(c(-c3ccccc3)n2n1)-c1ccc(cc1)C1(N)CCC1,0.0,0.0
fluphenazine-decanoate,CCCCCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1,0.0,0.0
BMY-7378,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1,0.0,0.0
dimesna,OS(=O)(=O)CCSSCCS(O)(=O)=O,0.0,0.0
anpirtoline,Clc1cccc(SC2CCNCC2)n1,0.0,0.0
KU-60019,C[C@H]1CN(CC(=O)Nc2ccc3Sc4c(Cc3c2)cccc4-c2cc(=O)cc(o2)N2CCOCC2)C[C@@H](C)O1,0.0,0.0
oxaliplatin,O=C1O[Pt]2(N[C@@H]3CCCC[C@H]3N2)OC1=O,0.0,0.0
mefenamic-acid,Cc1cccc(Nc2ccccc2C(O)=O)c1C,0.0,0.0
clinofibrate,"CCC(C)(Oc1ccc(cc1)C1(CCCCC1)c1ccc(O[C@](C)(CC)C(O)=O)cc1)C(O)=O |&1:22,&2:2,r|",0.0,0.0
cetilistat,CCCCCCCCCCCCCCCCOc1nc2ccc(C)cc2c(=O)o1,0.0,0.0
spectinomycin,CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@]3(O)[C@@H](O[C@H](C)CC3=O)O[C@@H]2[C@H]1O,0.0,0.0
nedocromil,CCCc1c2oc(cc(=O)c2cc2c1n(CC)c(cc2=O)C(O)=O)C(O)=O,0.0,0.0
OSI-027,COc1cccc2cc([nH]c12)-c1nc([C@H]2CC[C@@H](CC2)C(O)=O)n2ncnc(N)c12 |r|,0.0,0.0
asaraldehyde,COc1cc(OC)c(C=O)cc1OC,0.0,0.0
debrisoquin,NC(=N)N1CCc2ccccc2C1,0.0,0.0
benznidazole,[O-][N+](=O)c1nccn1CC(=O)NCc1ccccc1,0.0,0.0
medronic-acid,OP(O)(=O)CP(O)(O)=O,0.0,0.0
AC-55649,CCCCCCCCc1ccc(cc1)-c1ccc(cc1)C(O)=O,0.0,0.0
irsogladine,Nc1nc(N)nc(n1)-c1cc(Cl)ccc1Cl,0.0,0.0
sodium-nitroprusside,[O-][N+][Fe--](C#N)(C#N)(C#N)(C#N)C#N,0.0,0.0
G-15,"Brc1cc2OCOc2cc1[C@H]1Nc2ccccc2[C@H]2C=CC[C@@H]12 |&1:10,18,22,c:22|",0.0,0.0
anidulafungin,CCCCCOc1ccc(cc1)-c1ccc(cc1)-c1ccc(cc1)C(=O)N[C@H]1C[C@@H](O)[C@@H](O)NC(=O)[C@@H]2[C@@H](O)[C@@H](C)CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)c1ccc(O)cc1)[C@@H](C)O |r|,0.0,0.0
AZM-475271,COc1ccc(Cl)c(Nc2ncnc3cc(OCC4CCN(C)CC4)c(OC)cc23)c1,0.0,0.0
paritaprevir,Cc1cnc(cn1)C(=O)N[C@H]1CCCCC\C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]2C[C@H](CN2C1=O)Oc1nc2ccccc2c2ccccc12)C(=O)NS(=O)(=O)C1CC1 |c:17|,0.0,0.0
bamaquimast,CCCn1c2ccccc2nc(CCCOC(=O)NC)c1=O,0.0,0.0
epristeride,"[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C=C(CC[C@]12C)C(O)=O |c:25,t:23|",0.0,0.0
alpidem,CCCN(CCC)C(=O)Cc1c(nc2ccc(Cl)cn12)-c1ccc(Cl)cc1,0.0,0.0
BOS-172722,CCOc1cc(ccc1Nc1ncc2cc(C)nc(NCC(C)(C)C)c2n1)-c1nncn1C,0.0,0.0
sennoside-protonated,"OC[C@H]1O[C@@H](Oc2cccc3c(-c4c5cccc(O[C@H]6O[C@@H](CO)[C@@H](O)[C@@H](O)[C@@H]6O)c5c(O)c5c(O)cc(cc45)C(O)=O)c4cc(cc(O)c4c(O)c23)C(O)=O)[C@@H](O)[C@@H](O)[C@@H]1O |&1:2,&2:4,&3:19,&4:21,&5:24,&6:26,&7:28,&8:56,&9:58,&10:60,r|",0.0,0.0
GDC-0879,OCCn1cc(c(n1)-c1ccncc1)-c1ccc2\C(CCc2c1)=N\O,0.0,0.0
esaxerenone,Cc1c(cn(CCO)c1-c1ccccc1C(F)(F)F)C(=O)Nc1ccc(cc1)S(C)(=O)=O,0.0,0.0
brincidofovir,CCCCCCCCCCCCCCCCOCCCOP(O)(=O)CO[C@H](CO)Cn1ccc(N)nc1=O,0.0,0.0
ampalex,O=C(N1CCCCC1)c1ccc2nccnc2c1,0.0,0.0
BW-723C86,C[C@@H](N)Cc1c[nH]c2ccc(OCc3cccs3)cc12 |&1:1|,0.0,0.0
cipargamin,C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc21,0.0,0.0
nitenpyram,CCN(Cc1ccc(Cl)nc1)C(\NC)=C\[N+]([O-])=O,0.0,0.0
licochalcone-A,COc1cc(O)c(cc1\C=C\C(=O)c1ccc(O)cc1)C(C)(C)C=C,0.0,0.0
LY310762,CC1(C)C(=O)N(CCN2CCC(CC2)C(=O)c2ccc(F)cc2)c2ccccc12,0.0,0.0
aceglutamide,CC(=O)N[C@@H](CCC(N)=O)C(O)=O,0.0,0.0
baloxavir,[H][C@@]12COCCN1C(=O)c1c(O)c(=O)ccn1N2[C@@H]1c2ccccc2SCc2c(F)c(F)ccc12,0.0,0.0
1-acetyl-4-methylpiperazine,CN1CCN(CC1)C(C)=O,0.0,0.0
seratrodast,"CC1=C(C)C(=O)C([C@@H](CCCCCC(O)=O)c2ccccc2)=C(C)C1=O |r,c:1,t:22|",0.0,0.0
TC-F-2,CCn1c2ccccc2n([C@H]2CCCN(C2)c2nccc(n2)-c2cc3ccccc3o2)c1=O,0.0,0.0
lobeline,CN1[C@H](C[C@H](O)c2ccccc2)CCC[C@@H]1CC(=O)c1ccccc1,0.0,0.0
gallamine-triethiodide,CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC,0.0,0.0
moxaverine,CCc1cc2cc(OC)c(OC)cc2c(Cc2ccccc2)n1,0.0,0.0
PF-06305591,C[C@H]([C@H](N)c1nc2cc(ccc2[nH]1)C(C)(C)C)C(N)=O,0.0,0.0
UBP-302,N[C@@H](Cn1ccc(=O)n(Cc2ccccc2C(O)=O)c1=O)C(O)=O,0.0,0.0
quinelorane,CCCN1CCC[C@@H]2Cc3nc(N)ncc3C[C@@H]12,0.0,0.0
sodium-danshensu,O[C@@H](Cc1ccc(O)c(O)c1)C(O)=O |&1:1|,0.0,0.0
pelanserin,O=c1[nH]c2ccccc2c(=O)n1CCCN1CCN(CC1)c1ccccc1,0.0,0.0
ryuvidine,Cc1nc2c(s1)C(=O)C=C(Nc1ccc(C)cc1)C2=O |t:9|,0.0,0.0
pinitol,CO[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O,0.0,0.0
MPEP,Cc1cccc(n1)C#Cc1ccccc1,0.0,0.0
MK-571,CN(C)C(=O)CCS[C@@H](SCCC(O)=O)c1cccc(\C=C\c2ccc3ccc(Cl)cc3n2)c1 |&1:8|,0.0,0.0
tofacitinib,C[C@@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N,0.0,0.0
alpelisib,Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(c1)C(C)(C)C(F)(F)F,0.0,0.0
aprepitant,C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F,0.0,0.0
bismuth-oxalate,[Bi].[Bi].OC(=O)C(O)=O.OC(=O)C(O)=O.OC(=O)C(O)=O,0.0,0.0
SC-236,NS(=O)(=O)c1ccc(cc1)-n1nc(cc1-c1ccc(Cl)cc1)C(F)(F)F,0.0,0.0
clomifene,CCN(CC)CCOc1ccc(cc1)C(=C(/Cl)c1ccccc1)\c1ccccc1,0.0,0.0
sesamin,C1Oc2ccc(cc2O1)[C@H]1OC[C@H]2[C@@H]1CO[C@@H]2c1ccc2OCOc2c1,0.0,0.0
fluphenazine,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1,0.0,0.0
trilostane,"C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(=O)[C@@H](C[C@]35C)C#N)[C@@H]1CC[C@@H]2O |a:1,4,5,8,10,15,19,22,&1:13|",0.0,0.0
L-701324,Oc1c(-c2cccc(Oc3ccccc3)c2)c(=O)[nH]c2cc(Cl)ccc12,0.0,0.0
sulfadoxine,COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC,0.0,0.0
oxacillin,Cc1onc(c1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)-c1ccccc1,0.0,0.0
TH-302,Cn1c(COP(=O)(NCCBr)NCCBr)cnc1[N+]([O-])=O,0.0,0.0
zuranolone,[H][C@@]12CC[C@H](C(=O)Cn3cc(cn3)C#N)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@](C)(O)CC[C@]12[H],0.0,0.0
zibotentan,COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(cc1)-c1nnco1,0.0,0.0
gestodene,"CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1C=C[C@@]2(O)C#C |c:20,t:9|",0.0,0.0
L-670596,"CS(=O)(=O)c1ccc(Cn2c3[C@@H](CC(O)=O)CCCc3c3cc(F)cc(F)c23)cc1 |&1:11,r|",0.0,0.0
aprindine,CCN(CC)CCCN(C1Cc2ccccc2C1)c1ccccc1,0.0,0.0
pelrinone,Cc1nc(=O)c(C#N)c(NCc2cccnc2)[nH]1,0.0,0.0
MK-1903,OC(=O)c1n[nH]c2[C@@H]3C[C@@H]3Cc12,0.0,0.0
tramiprosate,NCCCS(O)(=O)=O,0.0,0.0
zinc-undecylenate,C=CCCCCCCCCC(=O)O[Zn]OC(=O)CCCCCCCCC=C,0.0,0.0
remoxipride,CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC,0.0,0.0
chloralose,OC[C@@H](O)[C@H]1O[C@@H]2O[C@@H](O[C@@H]2[C@H]1O)C(Cl)(Cl)Cl,0.0,0.0
"N-methyl-(-)ephedrine-[1R,2S]",C[C@@H]([C@H](O)c1ccccc1)N(C)C,0.0,0.0
TC-S-7009,[O-][N+](=O)c1c(Nc2cc(F)cc(Cl)c2)ccc2nonc12,0.0,0.0
propiverine,CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1,0.0,0.0
"2-ethyl-1,3-hexanediol","CCC[C@@H](O)[C@@H](CC)CO |&1:3,&2:5,r|",0.0,0.0
ibrutinib,Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)[C@@H]1CCCN(C1)C(=O)C=C,0.0,0.0
dichlorisone-acetate,"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](Cl)C[C@]12C |c:19,t:15|",0.0,0.0
darunavir,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1,0.0,0.0
guaiacol,COc1ccccc1O,0.0,0.0
DMP-777,CCC[C@@H](NC(=O)N1[C@@H](Oc2ccc(cc2)C(=O)N2CCN(C)CC2)C(CC)(CC)C1=O)c1ccc2OCOc2c1,0.0,0.0
1-phenylbiguanide,NC(N)=NC(=N)Nc1ccccc1,0.0,0.0
nemiralisib,CC(C)N1CCN(Cc2cnc(o2)-c2cc(cc3[nH]ncc23)-c2cccc3[nH]ccc23)CC1,0.0,0.0
amrinone,Nc1cc(c[nH]c1=O)-c1ccncc1,0.0,0.0
AZD1446,"Clc1ccc(o1)C(=O)N1C[C@H]2CNC[C@@H]2C1 |&1:10,&2:14,r|",0.0,0.0
cinepazide,COc1cc(\C=C\C(=O)N2CCN(CC(=O)N3CCCC3)CC2)cc(OC)c1OC,0.0,0.0
homatropine,"CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@@H](O)c1ccccc1 |a:2,5,7,&1:12,THB:9:7:1:3.4|",0.0,0.0
cis-ACPD,"[H][C@]1(CC[C@@](N)(C1)C(O)=O)C(O)=O |&1:1,4,r|",0.0,0.0
ATB-346,"COc1ccc2cc(ccc2c1)[C@@H](C)C(=O)Oc1ccc(cc1)C(N)=S |&1:12,r|",0.0,0.0
"1,4-butanediol",OCCCCO,0.0,0.0
AZD3759,COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C,0.0,0.0
crenigacestat,C[C@H](NC(=O)CCC(F)(F)F)C(=O)N[C@H]1c2ccccc2-c2cccnc2N(CCO)C1=O,0.0,0.0
astaxanthin,"C\C(\C=C\C=C(/C)\C=C\C1=C(C)C(=O)[C@@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C(=O)[C@@H](O)CC1(C)C |c:9,34|",0.0,0.0
quipazine,C1CN(CCN1)c1ccc2ccccc2n1,0.0,0.0
CD-437,OC(=O)c1ccc2cc(ccc2c1)-c1ccc(O)c(c1)C12CC3CC(CC(C3)C1)C2,0.0,0.0
A77636,NC[C@@H]1O[C@@H](Cc2c(O)c(O)ccc12)[C@@]12CC3CC(CC(C3)C1)C2,0.0,0.0
AS-604850,FC1(F)Oc2ccc(\C=C3/SC(=O)NC3=O)cc2O1,0.0,0.0
estradiol-valerate,CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C,0.0,0.0
"hydrastine-(1R,9S)",COc1ccc2[C@H](OC(=O)c2c1OC)[C@@H]1N(C)CCc2cc3OCOc3cc12,0.0,0.0
sulfatinib,CN(C)CCNS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4[nH]c(C)cc4c3)n2)c1,0.0,0.0
sulfacetamide,CC(=O)NS(=O)(=O)c1ccc(N)cc1,0.0,0.0
tributyrin,CCCC(=O)OCC(COC(=O)CCC)OC(=O)CCC,0.0,0.0
cortisone-acetate,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C |t:15|,0.0,0.0
PSNCBAM-1,Clc1ccc(NC(=O)Nc2cccc(c2)-c2cccc(n2)N2CCCC2)cc1,0.0,0.0
roxatidine-acetate,CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1,0.0,0.0
iopodic-acid,CN(C)\C=N\c1c(I)cc(I)c(CCC(O)=O)c1I,0.0,0.0
D-4476,NC(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccc2OCCOc2c1)-c1ccccn1,0.0,0.0
BU-239,C1CN=C(N1)c1cnc2ccccc2n1 |c:2|,0.0,0.0
RX-3117,Nc1ccn([C@H]2[C@H](O)[C@H](O)C(CO)=C2F)c(=O)n1 |c:12|,0.0,0.0
oleamide,CCCCCCCC\C=C/CCCCCCCC(N)=O,0.0,0.0
itraconazole,"CC[C@H](C)n1ncn(-c2ccc(cc2)N2CCN(CC2)c2ccc(OC[C@H]3CO[C@@](Cn4cncn4)(O3)c3ccc(Cl)cc3Cl)cc2)c1=O |&1:26,29,&2:2|",0.0,0.0
flumazenil,CCOC(=O)c1ncn-2c1CN(C)C(=O)c1cc(F)ccc-21,0.0,0.0
L-838417,Cn1ncnc1COc1nn2c(nnc2cc1C(C)(C)C)-c1cc(F)ccc1F,0.0,0.0
AM-404,CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)Nc1ccc(O)cc1,0.0,0.0
tiaprofenic-acid,"C[C@@H](C(O)=O)c1ccc(s1)C(=O)c1ccccc1 |&1:1,r|",0.0,0.0
edaglitazone,"Cc1oc(nc1CCOc1ccc(C[C@@H]2SC(=O)NC2=O)c2sccc12)-c1ccccc1 |&1:14,r|",0.0,0.0
altanserin,Fc1ccc(cc1)C(=O)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1,0.0,0.0
CFI-402257,Cc1cc(ccc1C(=O)NC1CC1)-c1cnn2c(NC[C@H]3C[C@@](C)(O)C3)cc(Oc3cccnc3)nc12 |r|,0.0,0.0
nornicotine,C1CN[C@H](C1)c1cccnc1 |r|,0.0,0.0
ronidazole,Cn1c(COC(N)=O)ncc1[N+]([O-])=O,0.0,0.0
carbaril,CNC(=O)Oc1cccc2ccccc12,0.0,0.0
argatroban,"C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)c1cccc2C[C@@H](C)CNc12 |a:1,5,12,&1:30|",0.0,0.0
chlorindanol,Oc1ccc(Cl)c2CCCc12,0.0,0.0
bromisoval,"CC(C)[C@@H](Br)C(=O)NC(N)=O |&1:3,r|",0.0,0.0
natamycin,"C[C@H]1O[C@@H](O[C@@H]2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(O)=O)C[C@@H](O)C[C@H]3O[C@@H]3\C=C\C(=O)O[C@H](C)C\C=C\C=C\C=C\C=C\2)[C@@H](O)[C@@H](N)[C@@H]1O |t:27,35,37,39,41|",0.0,0.0
CID-2745687,COC(=O)c1cnn(c1\C=N\NC(=S)NC(C)(C)C)-c1ccc(F)cc1F,0.0,0.0
mecarbinate,CCOC(=O)c1c(C)n(C)c2ccc(O)cc12,0.0,0.0
tamoxifen,CC\C(=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,0.0,0.0
AZ3146,COc1cc(OC2CCN(C)CC2)ccc1Nc1ncc2n(C)c(=O)n(C3CCCC3)c2n1,0.0,0.0
carbetocin,CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O,0.0,0.0
aphidicolin,C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H]1CC[C@H]1C[C@@H]3C[C@]21CC[C@]3(O)CO,0.0,0.0
"L-655,708",CCOC(=O)c1ncn-2c1[C@@H]1CCCN1C(=O)c1cc(OC)ccc-21,0.0,0.0
TC2559,CCOc1cncc(\C=C\CCNC)c1,0.0,0.0
TG-02,CN1C\C=C\CCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2 |t:3|,0.0,0.0
ML228,C(Nc1nc(nnc1-c1ccccc1)-c1ccccn1)c1ccc(cc1)-c1ccccc1,0.0,0.0
etifenin,CCc1cccc(CC)c1NC(=O)CN(CC(O)=O)CC(O)=O,0.0,0.0
avasimibe,CC(C)c1cc(C(C)C)c(CC(=O)NS(=O)(=O)Oc2c(cccc2C(C)C)C(C)C)c(c1)C(C)C,0.0,0.0
seladelpar,CCO[C@H](COc1ccc(cc1)C(F)(F)F)CSc1ccc(OCC(O)=O)c(C)c1,0.0,0.0
azelastine,CN1CCC[C@@H](CC1)n1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O |&1:5|,0.0,0.0
fosfluconazole,OP(O)(=O)OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,0.0,0.0
ACT-462206,COc1ccc(cc1)S(=O)(=O)N1CCC[C@H]1C(=O)Nc1cc(C)cc(C)c1,0.0,0.0
SYM-2081,C[C@H](C[C@H](N)C(O)=O)C(O)=O,0.0,0.0
sasapyrine,OC(=O)c1ccccc1OC(=O)c1ccccc1O,0.0,0.0
amezinium,COc1cc(N)cn[n+]1-c1ccccc1,0.0,0.0
CYT-997,CCC[C@H](Nc1nc(ncc1C)-c1ccc(NC(=O)NCC)c(OC)c1)c1cccnc1,0.0,0.0
SB-452533,CCN(CCNC(=O)Nc1ccccc1Br)c1cccc(C)c1,0.0,0.0
lusaperidone,Cc1nc2ccccn2c(=O)c1CCN1CCc2oc3ccccc3c2C1,0.0,0.0
U-0124,CSC(=N)C(C#N)C(C#N)C(=N)SC,0.0,0.0
metoxibutropate,"COc1ccccc1OC(=O)[C@@H](C)c1ccc(CC(C)C)cc1 |&1:11,r|",0.0,0.0
dapansutrile,CS(=O)(=O)CCC#N,0.0,0.0
CB-10-277,CN(C)\N=N\c1ccc(cc1)C(O)=O,0.0,0.0
naquotinib,CCc1nc(C(N)=O)c(Nc2ccc(cc2)N2CCC(CC2)N2CCN(C)CC2)nc1O[C@@H]1CCN(C1)C(=O)C=C,0.0,0.0
benzyl-isothiocyanate,S=C=NCc1ccccc1,0.0,0.0
isoflupredone-acetate,"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C |c:19,t:15|",0.0,0.0
ledipasvir,COC(=O)N[C@@H](C(C)C)C(=O)N1CC2(CC2)C[C@H]1c1nc(c[nH]1)-c1ccc2-c3ccc(cc3C(F)(F)c2c1)-c1ccc2nc([nH]c2c1)[C@@H]1[C@H]2CC[C@H](C2)N1C(=O)[C@@H](NC(=O)OC)C(C)C,0.0,0.0
capreomycin,C[C@@H]1NC(=O)[C@@H](N)CNC(=O)[C@@H](NC(=O)\C(NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC1=O)=C/NC(N)=O)[C@H]1CCN=C(N)N1 |t:43|,0.0,0.0
SU014813,Cc1[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,0.0,0.0
risedronate,OC(Cc1cccnc1)(P(O)(O)=O)P(O)(O)=O,0.0,0.0
alcaftadine,CN1CCC(CC1)=C1c2ncc(C=O)n2CCc2ccccc12,0.0,0.0
AZD3264,Cc1noc(C)c1-c1ccc(-c2cc(C(N)=O)c(NC(N)=O)s2)c(O[C@H]2CCNC2)c1,0.0,0.0
SGC-0946,CC(C)N(CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cc(Br)c2c(N)ncnc12,0.0,0.0
selegiline,C[C@H](Cc1ccccc1)N(C)CC#C,0.0,0.0
pemetrexed,Nc1nc(=O)c2c(CCc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)c[nH]c2[nH]1,0.0,0.0
andrographolide,C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H](C\C=C3/[C@H](O)COC3=O)C(=C)CC[C@H]12,0.0,0.0
clobetasol-propionate,"CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl |c:17,t:13|",0.0,0.0
CEP-37440,CNC(=O)c1ccccc1Nc1nc(Nc2ccc3C[C@H](CCCc3c2OC)N2CCN(CCO)CC2)ncc1Cl,0.0,0.0
nitroflurbiprofen,"C[C@@H](C(=O)OCCCCO[N+]([O-])=O)c1ccc(c(F)c1)-c1ccccc1 |&1:1,r|",0.0,0.0
elafibranor,CSc1ccc(cc1)C(=O)\C=C\c1cc(C)c(OC(C)(C)C(O)=O)c(C)c1,0.0,0.0
SU11274,CN(c1cccc(Cl)c1)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3[nH]c(C)c(C(=O)N4CCN(C)CC4)c3C)c2c1,0.0,0.0
edoxaban,CN(C)C(=O)[C@H]1CC[C@H](NC(=O)C(=O)Nc2ccc(Cl)cn2)[C@@H](C1)NC(=O)c1nc2CCN(C)Cc2s1,0.0,0.0
E-2001,Fc1ccc(cc1)C(=O)C1CCN(CC(=O)c2ccc3ccccc3c2)CC1,0.0,0.0
astilbin,C[C@@H]1O[C@@H](O[C@@H]2[C@H](Oc3cc(O)cc(O)c3C2=O)c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O,0.0,0.0
cefuroxime,CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(O)=O)c1ccco1 |c:16|,0.0,0.0
anethole,COc1ccc(\C=C\C)cc1,0.0,0.0
fumonisin-B1,CCCC[C@@H](C)[C@@H](OC(=O)C[C@@H](CC(O)=O)C(O)=O)[C@H](C[C@@H](C)C[C@H](O)CCCC[C@@H](O)C[C@H](O)[C@H](C)N)OC(=O)C[C@@H](CC(O)=O)C(O)=O,0.0,0.0
banoxantrone,C[N+](C)([O-])CCNc1ccc(NCC[N+](C)(C)[O-])c2C(=O)c3c(O)ccc(O)c3C(=O)c12,0.0,0.0
MC1568,Cn1c(\C=C\C(=O)NO)ccc1\C=C\C(=O)c1cccc(F)c1,0.0,0.0
fenoldopam,Oc1ccc(cc1)[C@H]1CNCCc2c(Cl)c(O)c(O)cc12 |&1:7|,0.0,0.0
benzofenac,OC(=O)Cc1ccc(OCc2ccccc2)c(Cl)c1,0.0,0.0
1400W,CC(=N)NCc1cccc(CN)c1,0.0,0.0
reversan,O=C(NCCCN1CCOCC1)c1cnn2c(cc(nc12)-c1ccccc1)-c1ccccc1,0.0,0.0
etizolam,CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl |c:16|,0.0,0.0
asenapine,"[H][C@]12CN(C)C[C@]1([H])c1cc(Cl)ccc1Oc1ccccc21 |&1:1,6|",0.0,0.0
PCI-27483,NC(=N)c1ccc2nc([nH]c2c1)-c1cc(CC(=O)N[C@@H](CC(O)=O)C(O)=O)cc(c1O)-c1cc(ccc1O)S(N)(=O)=O,0.0,0.0
rufinamide,NC(=O)c1cn(Cc2c(F)cccc2F)nn1,0.0,0.0
fostemsavir,COc1cnc(-n2cnc(C)n2)c2n(COP(O)(O)=O)cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c12,0.0,0.0
tenilsetam,"O=C1NCCN[C@@H]1c1cccs1 |&1:6,r|",0.0,0.0
nicaraven,"C[C@@H](CNC(=O)c1cccnc1)NC(=O)c1cccnc1 |&1:1,r|",0.0,0.0
resminostat,CN(C)Cc1ccc(cc1)S(=O)(=O)n1ccc(\C=C\C(=O)NO)c1,0.0,0.0
clopidol,Cc1[nH]c(C)c(Cl)c(=O)c1Cl,0.0,0.0
BMY-45778,OC(=O)COc1cccc(c1)-c1ocnc1-c1nc(c(o1)-c1ccccc1)-c1ccccc1,0.0,0.0
ELN-441958,Clc1cccc2CN(C(=O)c12)c1cccc(c1)C(=O)N1CCC2(CC1)CCN(CC2)c1ccncc1,0.0,0.0
A-987306,Nc1nc(N2CCNCC2)c2CCC3=C([C@@H]4CCCC[C@@H]4O3)c2n1 |t:14|,0.0,0.0
GSK2239633A,COc1cccc2n(Cc3cccc(CNC(=O)C(C)(C)O)c3)nc(NS(=O)(=O)c3ccc(Cl)s3)c12,0.0,0.0
BAY-41-2272,Nc1nc(ncc1C1CC1)-c1nn(Cc2ccccc2F)c2ncccc12,0.0,0.0
vigabatrin,N[C@@H](CCC(O)=O)C=C |&1:1|,0.0,0.0
CI-844,O(c1ccccc1)c1cccnc1,0.0,0.0
penicillin-v-potassium,CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(O)=O,0.0,0.0
simeprevir,COc1ccc2c(O[C@@H]3C[C@@H]4[C@@H](C3)C(=O)N(C)CCCC\C=C/[C@@H]3C[C@]3(NC4=O)C(=O)NS(=O)(=O)C3CC3)cc(nc2c1C)-c1nc(cs1)C(C)C |c:22|,0.0,0.0
dynole-34-2,CCCCCCCCNC(=O)C(=C\c1cn(CCCN(C)C)c2ccccc12)\C#N,0.0,0.0
LY320135,COc1ccc(cc1)-c1oc2cc(OC)ccc2c1C(=O)c1ccc(cc1)C#N,0.0,0.0
phenformin,NC(N)=NC(=N)NCCc1ccccc1,0.0,0.0
citric-acid,OC(=O)CC(O)(CC(O)=O)C(O)=O,0.0,0.0
cediranib,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,0.0,0.0
KU-0063794,COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1C[C@H](C)O[C@H](C)C1)N1CCOCC1,0.0,0.0
SCH-23390,CN1CCc2cc(Cl)c(O)cc2[C@H](C1)c1ccccc1,0.0,0.0
monensin,CC[C@]1(CC[C@@H](O1)[C@]1(C)CC[C@]2(C[C@H](O)[C@@H](C)[C@H](O2)[C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O1)[C@@H]1O[C@H](C[C@@H]1C)[C@H]1O[C@@](O)(CO)[C@H](C)C[C@@H]1C,0.0,0.0
Ro-4987655,OCCONC(=O)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F,0.0,0.0
IDO5L,Nc1nonc1\C(NO)=N/c1ccc(F)c(Cl)c1,0.0,0.0
CL-218872,Cc1nnc2ccc(nn12)-c1cccc(c1)C(F)(F)F,0.0,0.0
LXR-623,Fc1ccc(cc1)-c1n(Cc2ccc(F)cc2Cl)nc2c(cccc12)C(F)(F)F,0.0,0.0
lisadimate,"Nc1ccc(cc1)C(=O)OC[C@@H](O)CO |&1:11,r|",0.0,0.0
LY2828360,CN1CCN(CC1)c1nc(C)nc2n(C3CCOCC3)c(nc12)-c1ccccc1Cl,0.0,0.0
etoposide,COc1cc(cc(OC)c1O)[C@H]1[C@@H]2[C@H](COC2=O)[C@H](O[C@@H]2O[C@@H]3CO[C@@H](C)O[C@H]3[C@H](O)[C@H]2O)c2cc3OCOc3cc12,0.0,0.0
pimecrolimus,CC[C@@H]1\C=C(C)\C[C@H](C)C[C@H](OC)[C@H]2O[C@](O)([C@H](C)C[C@@H]2OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@@H]([C@H](C)[C@@H](O)CC1=O)C(\C)=C\[C@@H]1CC[C@H](Cl)[C@@H](C1)OC |c:3|,0.0,0.0
ranirestat,Fc1cc(Br)ccc1CN1C(=O)c2cccn2[C@@]2(CC(=O)NC2=O)C1=O,0.0,0.0
cryptotanshinone,C[C@H]1COC2=C1C(=O)C(=O)c1c3CCCC(C)(C)c3ccc21 |c:4|,0.0,0.0
bexagliflozin,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(Cl)c(Cc2ccc(OCCOC3CC3)cc2)c1,0.0,0.0
moxidectin,"[H][C@@]12OC\C3=C/C=C/[C@H](C)C\C(C)=C\C[C@]4([H])C[C@@]([H])(C[C@]5(C\C(=N/OC)[C@H](C)[C@H](O5)C(\C)=C\C(C)C)O4)OC(=O)[C@]([H])(C=C(C)[C@H]1O)[C@@]23O |c:4,t:6,12,45|",0.0,0.0
rucaparib,CNCc1ccc(cc1)-c1[nH]c2cc(F)cc3C(=O)NCCc1c23,0.0,0.0
lumefantrine,"CCCCN(CCCC)C[C@@H](O)c1cc(Cl)cc2\C(=C/c3ccc(Cl)cc3)c3cc(Cl)ccc3-c12 |&1:10,r|",0.0,0.0
FERb-033,O\N=C\c1ccc(c(Cl)c1O)-c1ccc(O)c(F)c1,0.0,0.0
AVL-292,COCCOc1ccc(Nc2ncc(F)c(Nc3cccc(NC(=O)C=C)c3)n2)cc1,0.0,0.0
ulipristal,"CN(C)c1ccc(cc1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(OC(C)=O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12 |t:29,36|",0.0,0.0
indomethacin,COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(O)=O)c2c1,0.0,0.0
VX-702,NC(=O)N(c1ccc(C(N)=O)c(n1)-c1ccc(F)cc1F)c1c(F)cccc1F,0.0,0.0
etebenecid,CCN(CC)S(=O)(=O)c1ccc(cc1)C(O)=O,0.0,0.0
monocrotaline,C[C@H]1C(=O)O[C@@H]2CCN3CC=C(COC(=O)[C@](C)(O)[C@]1(C)O)[C@H]23 |t:10|,0.0,0.0
hexoprenaline,"O[C@@H](CNCCCCCCNC[C@@H](O)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1 |&1:1,&2:12|",0.0,0.0
GSK461364,C[C@@H](Oc1cc(sc1C(N)=O)-n1cnc2ccc(CN3CCN(C)CC3)cc12)c1ccccc1C(F)(F)F,0.0,0.0
clofedanol,"CN(C)CC[C@@](O)(c1ccccc1)c1ccccc1Cl |&1:5,r|",0.0,0.0
mephenytoin,"CC[C@]1(NC(=O)N(C)C1=O)c1ccccc1 |&1:2,r|",0.0,0.0
gemfibrozil,Cc1ccc(C)c(OCCCC(C)(C)C(O)=O)c1,0.0,0.0
go-6983,COc1ccc2n(CCCN(C)C)cc(C3=C(C(=O)NC3=O)c3c[nH]c4ccccc34)c2c1 |t:15|,0.0,0.0
mibefradil,COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C,0.0,0.0
SB-203186,O=C(OCCN1CCCCC1)c1c[nH]c2ccccc12,0.0,0.0
ML298,Fc1cccc(c1)N1CNC(=O)C11CCN(CCNC(=O)c2ccc(F)c(F)c2)CC1,0.0,0.0
TH-588,Nc1nc(NC2CC2)cc(n1)-c1cccc(Cl)c1Cl,0.0,0.0
potassium-p-aminobenzoate,Nc1ccc(cc1)C(O)=O,0.0,0.0
macitentan-n-butyl-analogue,CCCCS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,0.0,0.0
carzenide,NS(=O)(=O)c1ccc(cc1)C(O)=O,0.0,0.0
manidipine,"COC(=O)C1=C(C)NC(C)=C([C@@H]1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN1CCN(CC1)C(c1ccccc1)c1ccccc1 |r,c:4,9|",0.0,0.0
emedastine,CCOCCn1c(nc2ccccc12)N1CCCN(C)CC1,0.0,0.0
allicin,"C=CCS[S@@](=O)CC=C |&1:4,r|",0.0,0.0
palbociclib,CC(=O)c1c(C)c2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n(C2CCCC2)c1=O,0.0,0.0
adrenosterone,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CCC2=O |t:9|,0.0,0.0
LY294002,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,0.0,0.0
BNC105,COc1ccc2c(C(=O)c3cc(OC)c(OC)c(OC)c3)c(C)oc2c1O,0.0,0.0
aminomethyltransferase,"C[C@H]1CCN=C(N)S1 |&1:1,t:4|",0.0,0.0
cipamfylline,Nc1nc2n(CC3CC3)c(=O)n(CC3CC3)c(=O)c2[nH]1,0.0,0.0
cilofexor,OC(=O)c1ccnc(c1)N1CC(O)(C1)c1ccc(OCc2c(onc2-c2c(Cl)cccc2Cl)C2CC2)cc1Cl,0.0,0.0
eleclazine,FC(F)(F)Oc1ccc(cc1)-c1ccc2OCCN(Cc3ncccn3)C(=O)c2c1,0.0,0.0
IKK-16,O=C(N1CCC(CC1)N1CCCC1)c1ccc(Nc2nccc(n2)-c2cc3ccccc3s2)cc1,0.0,0.0
proacipimox,COCc1c[n+]([O-])c(C)cn1,0.0,0.0
chiniofon,Oc1c(I)cc(c2cccnc12)S(O)(=O)=O,0.0,0.0
LM-22A4,OCCNC(=O)c1cc(cc(c1)C(=O)NCCO)C(=O)NCCO,0.0,0.0
cephradine,"CC1=C(N2[C@@H](SC1)[C@H](NC(=O)[C@H](N)C1=CCC=CC1)C2=O)C(O)=O |a:7,11,&1:4,c:17,t:1,14|",0.0,0.0
BRD7389,O=C1c2ccccc2-c2c(NCCc3ccccc3)c(=O)[nH]c3cccc1c23,0.0,0.0
xaliproden,FC(F)(F)c1cccc(c1)C1=CCN(CCc2ccc3ccccc3c2)CC1 |t:11|,0.0,0.0
BIBX-1382,CN1CCC(CC1)Nc1ncc2ncnc(Nc3ccc(F)c(Cl)c3)c2n1,0.0,0.0
nifursol,Oc1c(cc(cc1[N+]([O-])=O)[N+]([O-])=O)C(=O)N\N=C\c1ccc(o1)[N+]([O-])=O,0.0,0.0
ornidazole,"Cc1ncc(n1C[C@@H](O)CCl)[N+]([O-])=O |&1:7,r|",0.0,0.0
beta-glycerophosphoric-acid,OCC(CO)OP(O)(O)=O,0.0,0.0
torcitabine,Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1,0.0,0.0
mivacurium,"COc1cc2CC[N@@+](C)(CCCOC(=O)CC\C=C\CCC(=O)OCCC[N@@+]3(C)CCc4cc(OC)c(OC)cc4[C@H]3Cc3cc(OC)c(OC)c(OC)c3)[C@H](Cc3cc(OC)c(OC)c(OC)c3)c2cc1OC |a:41,55,&1:7,&2:27|",0.0,0.0
naftopidil,COc1ccccc1N1CCN(C[C@@H](O)COc2cccc3ccccc23)CC1 |&1:13|,0.0,0.0
ursolic-acid,C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2[C@H]1C)C(O)=O |c:9|,0.0,0.0
spiramycin,"CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]1O[C@H](C)[C@@H](O[C@H]2C[C@@](C)(O)[C@@H](O)[C@H](C)O2)[C@@H]([C@H]1O)N(C)C |t:12,14|",0.0,0.0
E7820,Cc1ccc(NS(=O)(=O)c2cccc(c2)C#N)c2[nH]cc(C#N)c12,0.0,0.0
losartan,CCCCc1nc(Cl)c(CO)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1,0.0,0.0
gemigliptin,N[C@H](CN1CC(F)(F)CCC1=O)CC(=O)N1CCc2c(C1)nc(nc2C(F)(F)F)C(F)(F)F,0.0,0.0
gadodiamide,CNC(=O)CN1CCN2CCN(CC(=O)NC)CC(=O)O[Gd](OC(=O)C1)OC(=O)C2,0.0,0.0
nitrendipine,"CCOC(=O)C1=C(C)NC(C)=C([C@@H]1c1cccc(c1)[N+]([O-])=O)C(=O)OC |r,c:5,10|",0.0,0.0
cytochalasin-B,"C[C@H]1[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]22OC(=O)\C=C\[C@H](O)CCC[C@@H](C)C\C=C\[C@H]2[C@H](O)C1=C |t:20,30|",0.0,0.0
alogliptin,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O,0.0,0.0
pyrazoloacridine,COc1ccc2nc3c(ccc4n(CCCN(C)C)[nH]c(c34)c2c1)[N+]([O-])=O,0.0,0.0
droxidopa,N[C@@H]([C@H](O)c1ccc(O)c(O)c1)C(O)=O,0.0,0.0
eperisone,CCc1ccc(cc1)C(=O)[C@@H](C)CN1CCCCC1 |r|,0.0,0.0
chromocarb,OC(=O)c1cc(=O)c2ccccc2o1,0.0,0.0
walrycin-B,Cn1nc(nc2c1nc(=O)n(C)c2=O)-c1ccc(cc1)C(F)(F)F,0.0,0.0
pyridoxal,Cc1ncc(CO)c(C=O)c1O,0.0,0.0
butylidenephthalide,CCC\C=C1/OC(=O)c2ccccc12,0.0,0.0
pexidartinib,FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1,0.0,0.0
linsitinib,C[C@@]1(O)C[C@@H](C1)c1nc(-c2ccc3ccc(nc3c2)-c2ccccc2)c2c(N)nccn12 |r|,0.0,0.0
NAS-181,C(Oc1cccc2C=C(CN3CCOCC3)COc12)[C@H]1CNCCO1 |t:7|,0.0,0.0
isosorbide-mononitrate,O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)O[N+]([O-])=O,0.0,0.0
AZD9496,C[C@@H]1Cc2c([nH]c3ccccc23)[C@H](N1CC(C)(C)F)c1c(F)cc(\C=C\C(O)=O)cc1F,0.0,0.0
ZK-164015,CCCCCS(=O)(=O)CCCCCCCCCCn1c(c(C)c2cc(O)ccc12)-c1ccc(O)cc1,0.0,0.0
etrabamine,"CN[C@H]1CCc2ncsc2C1 |&1:2,r|",0.0,0.0
ceruletide,[H][C@](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)([C@@H](C)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,0.0,0.0
CRT0044876,OC(=O)c1cc2cccc([N+]([O-])=O)c2[nH]1,0.0,0.0
salinomycin,CC[C@H]([C@H]1CC[C@H](C)[C@@H](O1)[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]1O[C@@]2(O[C@@]3(CC[C@](C)(O3)[C@H]3CC[C@](O)(CC)[C@H](C)O3)[C@H](O)C=C2)[C@H](C)C[C@@H]1C)C(O)=O |c:46|,0.0,0.0
oleandrin,CO[C@H]1C[C@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3CC[C@]3(C)[C@H]([C@H](C[C@]43O)OC(C)=O)C3=CC(=O)OC3)C2)O[C@@H](C)[C@@H]1O |t:32|,0.0,0.0
N-methylformamide,CNC=O,0.0,0.0
taltobulin,CN[C@H](C(=O)N[C@H](C(=O)N(C)[C@H](\C=C(/C)C(O)=O)C(C)C)C(C)(C)C)C(C)(C)c1ccccc1,0.0,0.0
NSC-319726,C\C(=N/NC(=S)N1CCC1)c1ccccn1,0.0,0.0
ebrotidine,NC(=N)Nc1nc(CSCCN\C=N\S(=O)(=O)c2ccc(Br)cc2)cs1,0.0,0.0
ML347,COc1ccc(cc1)-c1cnc2c(cnn2c1)-c1cccc2ncccc12,0.0,0.0
itacitinib,Fc1c(ccnc1C(F)(F)F)C(=O)N1CCC(CC1)N1CC(CC#N)(C1)n1cc(cn1)-c1ncnc2[nH]ccc12,0.0,0.0
fucoxanthin,[H]C(=[C@@]=C1C(C)(C)C[C@@H](C[C@@]1(C)O)OC(C)=O)C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C(=O)C[C@]12O[C@@]1(C)C[C@H](O)CC2(C)C,0.0,0.0
NQDI-1,CCOC(=O)c1c2-c3ccccc3C(=O)c3cccc([nH]c1=O)c23,0.0,0.0
protriptyline,CNCCCC1c2ccccc2C=Cc2ccccc12 |c:13|,0.0,0.0
trimetozine,COc1cc(cc(OC)c1OC)C(=O)N1CCOCC1,0.0,0.0
BGT226,COc1ccc(cn1)-c1ccc2ncc3n(C)c(=O)n(-c4ccc(N5CCNCC5)c(c4)C(F)(F)F)c3c2c1,0.0,0.0
etonogestrel,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC(=C)[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H] |c:23|,0.0,0.0
proxymetacaine,CCCOc1ccc(cc1N)C(=O)OCCN(CC)CC,0.0,0.0
melphalan,N[C@@H](Cc1ccc(cc1)N(CCCl)CCCl)C(O)=O,0.0,0.0
YIL-781,CC(C)N1CCC[C@H](Cn2c(C)nc3ccc(Oc4ccc(F)cc4)cc3c2=O)C1,0.0,0.0
EPZ020411,CNCCN(C)Cc1c[nH]nc1-c1ccc(O[C@H]2C[C@@H](C2)OCCC2CCOCC2)cc1 |r|,0.0,0.0
metaproterenol,CC(C)NC[C@@H](O)c1cc(O)cc(O)c1 |&1:5|,0.0,0.0
ML9,Clc1cccc2c(cccc12)S(=O)(=O)N1CCCNCC1,0.0,0.0
cimetropium,"C[N@@+]1(CC2CC2)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)c1ccccc1 |a:6,8,10,11,13,17,&1:1,TLB:0:1:7.8.9:11.13,THB:2:1:7.8.9:11.13,12:11:1:7.8.9,12:13:1:7.8.9,14:8:1:11.13|",0.0,0.0
lonafarnib,NC(=O)N1CCC(CC(=O)N2CCC(CC2)[C@H]2c3ncc(Br)cc3CCc3cc(Cl)cc(Br)c23)CC1,0.0,0.0
LSZ-102,CC(F)(F)c1cc(F)ccc1-c1sc2cc(O)ccc2c1Oc1ccc(\C=C\C(O)=O)cc1,0.0,0.0
NVP-DPP728,O=C(CNCCNc1ccc(cn1)C#N)N1CCC[C@H]1C#N,0.0,0.0
sulfafurazole,Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C,0.0,0.0
LY266097,COc1ccc(C[C@H]2NCCc3c2[nH]c2ccc(C)cc32)c(Cl)c1OC |&1:7|,0.0,0.0
WIKI4,COc1ccc(cc1)-n1c(SCCCN2C(=O)c3cccc4cccc(C2=O)c34)nnc1-c1ccncc1,0.0,0.0
cholecalciferol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,0.0,0.0
AC-7954-(+/-),CN(C)CC[C@]1(Cc2ccccc2C(=O)O1)c1ccc(Cl)cc1 |&1:5|,0.0,0.0
nebivolol,"O[C@H](CNC[C@@H](O)[C@@H]1CCc2cc(F)ccc2O1)[C@H]1CCc2cc(F)ccc2O1 |&1:1,5,7,18|",0.0,0.0
DSR-6434,CCCCNc1nc(N)c2[nH]c(=O)n(Cc3ccc(OCCN(C)C)nc3)c2n1,0.0,0.0
vonoprazan,CNCc1cc(-c2ccccc2F)n(c1)S(=O)(=O)c1cccnc1,0.0,0.0
regorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,0.0,0.0
arundic-acid,CCCCCC[C@@H](CCC)C(O)=O,0.0,0.0
arglabin,CC1=CC[C@]23O[C@@]2(C)CC[C@@H]2[C@H](OC(=O)C2=C)[C@@H]13 |t:1|,0.0,0.0
lactulose,OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O,0.0,0.0
trans-4-hydroxycrotonic-acid,OC\C=C\C(O)=O,0.0,0.0
mexeneone,COc1ccc(C(=O)c2ccc(C)cc2)c(O)c1,0.0,0.0
tinoridine,CCOC(=O)c1c(N)sc2CN(Cc3ccccc3)CCc12,0.0,0.0
iberdomide,O=C1N(Cc2c1cccc2OCc1ccc(CN2CCOCC2)cc1)[C@H]1CCC(=O)NC1=O,0.0,0.0
ozagrel,OC(=O)\C=C\c1ccc(Cn2ccnc2)cc1,0.0,0.0
MDL-27531,Cn1c(nnc1S(C)(=O)=O)-c1ccccc1,0.0,0.0
tibolone,"C[C@@H]1CC2=C(CCC(=O)C2)[C@H]2CC[C@@]3(C)[C@H](CC[C@@]3(O)C#C)[C@@H]12 |a:1,10,13,15,18,&1:22,t:3|",0.0,0.0
pyronaridine,COc1ccc2nc3cc(Cl)ccc3c(Nc3cc(CN4CCCC4)c(O)c(CN4CCCC4)c3)c2n1,0.0,0.0
fenthion,COP(=S)(OC)Oc1ccc(SC)c(C)c1,0.0,0.0
sitosterol,CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C |t:13|,0.0,0.0
3-hydroxy-3-phenylpentanamide,"CC[C@@](O)(CC(N)=O)c1ccccc1 |&1:2,r|",0.0,0.0
narasin,"CC[C@H]([C@@H]1O[C@@H]([C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2O[C@@]3(O[C@@]4(CC[C@](C)(O4)[C@H]4CC[C@](O)(CC)[C@H](C)O4)[C@H](O)C=C3)[C@H](C)C[C@@H]2C)[C@@H](C)C[C@H]1C)C(O)=O |a:2,3,5,6,8,10,14,17,19,21,24,30,34,37,41,44,46,49,&1:27,c:41|",0.0,0.0
nimesulide,CS(=O)(=O)Nc1ccc(cc1Oc1ccccc1)[N+]([O-])=O,0.0,0.0
C11-Acetate,[Y+3],0.0,0.0
benidipine,COC(=O)C1=C(C)NC(C)=C([C@@H]1c1cccc(c1)[N+]([O-])=O)C(=O)O[C@@H]1CCCN(Cc2ccccc2)C1,0.0,0.0
trofosfamide,"ClCCN(CCCl)[P@@]1(=O)OCCCN1CCCl |&1:7,r|",0.0,0.0
CGP-78608,C[C@@H](NCc1cc(Br)cc2[nH]c(=O)c(=O)[nH]c12)P(O)(O)=O,0.0,0.0
GSK3179106,CCOc1cc(=O)[nH]cc1-c1ccc(CC(=O)Nc2cc(on2)C(C)(C)C(F)(F)F)c(F)c1,0.0,0.0
eltoprazine,C1CN(CCN1)c1cccc2OCCOc12,0.0,0.0
SKF-81297,Oc1cc2C(CNCCc2c(Cl)c1O)c1ccccc1,0.0,0.0
desoxycortone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO |t:8|,0.0,0.0
BMS-214662,O=S(=O)(N1Cc2cc(ccc2N(Cc2cnc[nH]2)C[C@H]1Cc1ccccc1)C#N)c1cccs1,0.0,0.0
teicoplanin-A2-1,"CCCCC\C=C\CCC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1Oc1c2Oc3ccc(C[C@H]4NC(=O)[C@H](N)c5ccc(O)c(Oc6cc(O)cc(c6)[C@H](NC4=O)C(=O)N[C@@H]4c(c2)cc1Oc1ccc(cc1Cl)[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O)[C@@H]1NC(=O)[C@H](NC4=O)c2ccc(O)c(c2)-c2c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc2[C@H](NC1=O)C(O)=O)c5)cc3Cl |a:12,13,15,17,21,35,51,58,71,73,75,78,80,82,87,91,107,110,112,114,121,&1:31,&2:105|",0.0,0.0
nifurtimox,"C[C@H]1CS(=O)(=O)CCN1\N=C\c1ccc(o1)[N+]([O-])=O |&1:1,r|",0.0,0.0
CEP-37440,CNC(=O)c1ccccc1Nc1nc(Nc2ccc3C[C@H](CCCc3c2OC)N2CCN(CCO)CC2)ncc1Cl,0.0,0.0
BTS,Cc1ccc(cc1)S(=O)(=O)NCc1ccccc1,0.0,0.0
palomid-529,"COc1ccc(COc2cc3oc(=O)c4cc(ccc4c3cc2OC)[C@@H](C)O)cc1 |&1:25,r|",0.0,0.0
thiotepa,S=P(N1CC1)(N1CC1)N1CC1,0.0,0.0
BRL-52537,Clc1ccc(CC(=O)N2CCCC[C@@H]2CN2CCCC2)cc1Cl |&1:13|,0.0,0.0
zoxazolamine,Nc1nc2cc(Cl)ccc2o1,0.0,0.0
TPCA-1,NC(=O)Nc1sc(cc1C(N)=O)-c1ccc(F)cc1,0.0,0.0
sulfaquinoxaline,Nc1ccc(cc1)S(=O)(=O)Nc1cnc2ccccc2n1,0.0,0.0
nibentan,"CCN(CC)CCCC[C@@H](NC(=O)c1ccc(cc1)[N+]([O-])=O)c1ccccc1 |&1:9,r|",0.0,0.0
iloprost,"CC#CC[C@@H](C)[C@H](O)\C=C\[C@H]1[C@H](O)C[C@@H]2C\C(C[C@H]12)=C/CCCC(O)=O |a:6,10,11,14,18,&1:4|",0.0,0.0
XL041,CC(C)(O)c1cn(c(n1)C(C)(C)c1c(Cl)cccc1Cl)-c1ccc(cc1F)-c1cc(F)c(CO)c(c1)S(C)(=O)=O,0.0,0.0
4-iodo-6-phenylpyrimidine,Ic1cc(ncn1)-c1ccccc1,0.0,0.0
metacetamol,CC(=O)Nc1cccc(O)c1,0.0,0.0
medroxyprogesterone,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(C)=O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CCC(=O)C=C12 |t:25|,0.0,0.0
L-arginine,N[C@@H](CCCNC(N)=N)C(O)=O,0.0,0.0
ciproxifan,O=C(C1CC1)c1ccc(OCCCc2cnc[nH]2)cc1,0.0,0.0
levodopa,N[C@@H](Cc1ccc(O)c(O)c1)C(O)=O,0.0,0.0
delivert,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@@H]1C(=O)N[C@H](Cc1ccccc1)C(O)=O,0.0,0.0
BAG-956,Cc1nc2cnc3ccc(cc3c2n1-c1ccc(cc1)C(C)(C)C#N)C#Cc1cccnc1,0.0,0.0
phenserine,CN1CC[C@]2(C)[C@H]1N(C)c1ccc(OC(=O)Nc3ccccc3)cc21,0.0,0.0
sucrose,OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O,0.0,0.0
hydrocortisone,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO |t:9|,0.0,0.0
PD-173074,CCN(CC)CCCCNc1ncc2cc(c(NC(=O)NC(C)(C)C)nc2n1)-c1cc(OC)cc(OC)c1,0.0,0.0
eprinomectin,"[H][C@@]12OC\C3=C/C=C/[C@]([H])(C)[C@]([H])(O[C@@]4([H])C[C@H](OC)[C@@H](O[C@@]5([H])C[C@H](OC)[C@@H](NC(C)=O)[C@H](C)O5)[C@H](C)O4)\C(C)=C\C[C@]4([H])C[C@@]([H])(C[C@]5(O4)O[C@]([H])([C@@H](C)CC)[C@@]([H])(C)C=C5)OC(=O)[C@]([H])(C=C(C)[C@@]1([H])O)[C@@]23O |c:4,64,t:6,42,72|",0.0,0.0
pyroxamide,ONC(=O)CCCCCCC(=O)Nc1cccnc1,0.0,0.0
fenaclon,ClCCC(=O)NCCc1ccccc1,0.0,0.0
secoisolariciresinol-diglucoside,COc1cc(C[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)Cc2ccc(O)c(OC)c2)ccc1O,0.0,0.0
olodanrigan,COc1ccc2CN([C@@H](Cc2c1OCc1ccccc1)C(O)=O)C(=O)C(c1ccccc1)c1ccccc1,0.0,0.0
anacetrapib,COc1cc(F)c(cc1-c1ccc(cc1CN1[C@@H](C)[C@H](OC1=O)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)C(F)(F)F)C(C)C,0.0,0.0
GR-127935,COc1ccc(NC(=O)c2ccc(cc2)-c2ccc(cc2C)-c2noc(C)n2)cc1N1CCN(C)CC1,0.0,0.0
clomethiazole,Cc1ncsc1CCCl,0.0,0.0
GSK256066,COc1cccc(Nc2c(cnc3c(C)cc(cc23)S(=O)(=O)c2cccc(c2)C(=O)N(C)C)C(N)=O)c1,0.0,0.0
telcagepant,Fc1cccc([C@@H]2CC[C@@H](NC(=O)N3CCC(CC3)n3c4cccnc4[nH]c3=O)C(=O)N(CC(F)(F)F)C2)c1F,0.0,0.0
pirlindole,Cc1ccc2n3CCN[C@H]4CCCc(c34)c2c1 |&1:9|,0.0,0.0
anabasine,"C1CC[C@@H](NC1)c1cccnc1 |&1:3,r|",0.0,0.0
TCS-3035,OC(=O)COc1ccc(\C=C2/SC(=O)NC2=O)cc1,0.0,0.0
sulbutiamine,CC(C)C(=O)OCC\C(SS\C(CCOC(=O)C(C)C)=C(/C)N(Cc1cnc(C)nc1N)C=O)=C(\C)N(Cc1cnc(C)nc1N)C=O,0.0,0.0
nemorexant,COc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2ccc(Cl)c(C)c2[nH]1)-n1nccn1,0.0,0.0
indirubin-3-monoxime,O\N=C1\C(\Nc2ccccc\12)=C1\C(=O)Nc2ccccc12,0.0,0.0
allantoin,NC(=O)N[C@H]1NC(=O)NC1=O |r|,0.0,0.0
galidesivir,Nc1ncnc2c(c[nH]c12)[C@@H]1N[C@H](CO)[C@@H](O)[C@H]1O,0.0,0.0
lobenzarit,OC(=O)c1ccccc1Nc1cc(Cl)ccc1C(O)=O,0.0,0.0
GLPG0492-R-enantiomer,CN1C(=O)N(C(=O)[C@]1(CO)c1ccccc1)c1ccc(C#N)c(c1)C(F)(F)F,0.0,0.0
YO-01027,C[C@H](NC(=O)Cc1cc(F)cc(F)c1)C(=O)N[C@H]1c2ccccc2-c2ccccc2N(C)C1=O,0.0,0.0
equol,Oc1ccc(cc1)[C@H]1COc2cc(O)ccc2C1,0.0,0.0
voriconazole,C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,0.0,0.0
rimexolone,"CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C |c:17,t:13|",0.0,0.0
lenalidomide,"Nc1cccc2C(=O)N(Cc12)[C@H]1CCC(=O)NC1=O |&1:11,r|",0.0,0.0
tifenazoxide,CC1(CC1)NC1=NS(=O)(=O)c2sc(Cl)cc2N1 |t:6|,0.0,0.0
nilvadipine,"COC(=O)C1=C(NC(C)=C([C@@H]1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)C)C#N |&1:10,r,c:8,t:4|",0.0,0.0
retagliptin,COC(=O)c1nc(n2CCN(Cc12)C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F)C(F)(F)F,0.0,0.0
probucol,CC(C)(Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C,0.0,0.0
PD-198306,Cc1cc(I)ccc1Nc1c(F)c(F)c(F)cc1C(=O)NOCC1CC1,0.0,0.0
ethynylcytidine,Nc1ccn([C@@H]2O[C@H](CO)[C@](O)(C#C)[C@H]2O)c(=O)n1,0.0,0.0
epigallocatechin-(-),O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1,0.0,0.0
vericiguat,COC(=O)Nc1c(N)nc(nc1N)-c1nn(Cc2ccccc2F)c2ncc(F)cc12,0.0,0.0
PF-06412562,Cc1cc(Oc2nccc3[nH]ncc23)ccc1-c1c(C)ncnc1C,0.0,0.0
landiolol,CC1(C)OC[C@@H](COC(=O)CCc2ccc(OC[C@@H](O)CNCCNC(=O)N3CCOCC3)cc2)O1,0.0,0.0
atomoxetine,CNCC[C@@H](Oc1ccccc1C)c1ccccc1,0.0,0.0
salvianolic-acid-B,OC(=O)[C@@H](Cc1ccc(O)c(O)c1)OC(=O)\C=C\c1ccc(O)c2O[C@H]([C@H](C(=O)O[C@H](Cc3ccc(O)c(O)c3)C(O)=O)c12)c1ccc(O)c(O)c1,0.0,0.0
chlorpropamide,CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1,0.0,0.0
dextrorotation-nimorazole-phosphate-ester,Cc1ncc(n1C[C@@H](CN1CCOCC1)OP(O)(O)=O)[N+]([O-])=O,0.0,0.0
pimobendan,"COc1ccc(cc1)-c1nc2ccc(cc2[nH]1)C1=NNC(=O)C[C@H]1C |&1:23,t:20|",0.0,0.0
GNE-7915,CCNc1nc(Nc2cc(F)c(cc2OC)C(=O)N2CCOCC2)ncc1C(F)(F)F,0.0,0.0
octocrylene,CCCC[C@@H](CC)COC(=O)C(C#N)=C(c1ccccc1)c1ccccc1 |&1:4|,0.0,0.0
SR-95639A,C(CN1CCOCC1)Nc1cc2CCCc3ccccc3-c2nn1,0.0,0.0
omtriptolide,[H][C@@]12C[C@@H]3O[C@@]33[C@H](OC(=O)CCC(O)=O)[C@]4(O[C@H]4[C@@H]4O[C@]34[C@@]1(C)CCC1=C2COC1=O)C(C)C |c:30|,0.0,0.0
ASP-6537,COc1nc(-c2ccc(OC)cc2)n(n1)-c1ccc(OC)cc1,0.0,0.0
WAY-600,C(N1CCC(CC1)n1ncc2c(nc(nc12)-c1ccc2[nH]ccc2c1)N1CCOCC1)c1cccnc1,0.0,0.0
oxibendazole,CCCOc1ccc2nc(NC(=O)OC)[nH]c2c1,0.0,0.0
ZD-0947,"FC(F)(F)C1=C[C@H](C2=C(CCCC2=O)N1)c1cccc(c1)C#N |t:4,7|",0.0,0.0
carbazochrome,"CN1[C@@H](CC2=C\C(=N\NC(N)=O)C(=O)C=C12)S(O)(=O)=O |&1:2,t:4,14|",0.0,0.0
beta-carotene,"C\C(\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)CCCC1(C)C |c:9,32|",0.0,0.0
amiprilose,CN(C)CCCO[C@H]1[C@H](O[C@@H]2OC(C)(C)O[C@H]12)[C@H](O)CO,0.0,0.0
methylprednisolone,"C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12 |c:23,t:27|",0.0,0.0
difluprednate,"CCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)COC(C)=O |c:18,t:14|",0.0,0.0
AJ76-(+),CCCN[C@@H]1CCc2c(OC)cccc2[C@@H]1C,0.0,0.0
hydrocortisone-hemisuccinate,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCC(O)=O |t:9|,0.0,0.0
seocalcitol,CCC(O)(CC)\C=C\C=C\[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C,0.0,0.0
JW-55,COc1ccc(cc1)C1(CNC(=O)c2ccc(NC(=O)c3ccco3)cc2)CCOCC1,0.0,0.0
SCH-900776,Cn1cc(cn1)-c1cnn2c(N)c(Br)c(nc12)[C@@H]1CCCNC1,0.0,0.0
"2,3-cis/exo-pinanediol",CC1(C)C2CC1[C@](C)(O)[C@H](O)C2,0.0,0.0
GW-441756,Cn1cc(\C=C2/C(=O)Nc3cccnc23)c2ccccc12,0.0,0.0
BMS-986195,CC#CC(=O)N[C@H]1CCCN(C1)c1c(F)cc(C(N)=O)c2[nH]c(C)c(C)c12,0.0,0.0
triclocarban,Clc1ccc(NC(=O)Nc2ccc(Cl)c(Cl)c2)cc1,0.0,0.0
tivantinib,O=C1NC(=O)[C@H]([C@@H]1c1c[nH]c2ccccc12)c1cn2CCCc3cccc1c23,0.0,0.0
KU14R,"CC[C@]1(Cc2ccccc2O1)c1ncc[nH]1 |&1:2,r|",0.0,0.0
chlorophyllin,CCc1c(C)c2cc3nc(cc4[nH]c([C@@H](CCC(O)=O)[C@@H]4C)c(CC(O)=O)c4[nH]c(cc1n2)c(C)c4C(O)=O)c(C)c3C=C,0.0,0.0
anisomycin,COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1,0.0,0.0
picartamide,"CNC(=S)[C@]1(CCCS1)c1ccccn1 |&1:4,r|",0.0,0.0
iopamidol,C[C@H](O)C(=O)Nc1c(I)c(C(=O)NC(CO)CO)c(I)c(C(=O)NC(CO)CO)c1I,0.0,0.0
droxicam,CN1c2c(oc(=O)n(-c3ccccn3)c2=O)-c2ccccc2S1(=O)=O,0.0,0.0
Ro-5126766,CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F,0.0,0.0
gadobutrol,"[H]O[C@@H](CO)[C@H](CO)N1CCN2CCN3CCN(CC1)CC(=O)O[Gd](OC(=O)C3)OC(=O)C2 |&1:2,5|",0.0,0.0
rigosertib,COc1cc(OC)c(\C=C\S(=O)(=O)Cc2ccc(OC)c(NCC(O)=O)c2)c(OC)c1,0.0,0.0
lusutrombopag,CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(\C=C(/C)C(O)=O)c(Cl)c3)n2)c1OC,0.0,0.0
aceclidine,"CC(=O)O[C@H]1CN2CCC1CC2 |&1:4,r|",0.0,0.0
epothilone-B,C[C@H]1CCC[C@@]2(C)O[C@H]2C[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\c1csc(C)n1,0.0,0.0
sulfadiazine,Nc1ccc(cc1)S(=O)(=O)Nc1ncccn1,0.0,0.0
etofylline,Cn1c2ncn(CCO)c2c(=O)n(C)c1=O,0.0,0.0
baloxavir-marboxil,[H][C@@]12COCCN1C(=O)c1c(OCOC(=O)OC)c(=O)ccn1N2[C@H]1c2ccc(F)c(F)c2CSc2ccccc12,0.0,0.0
cefonicid,O[C@@H](C(=O)N[C@H]1[C@H]2SCC(CSc3nnnn3CS(O)(=O)=O)=C(N2C1=O)C(O)=O)c1ccccc1 |c:22|,0.0,0.0
CHPG,"N[C@@H](C(O)=O)c1cc(O)ccc1Cl |&1:1,r|",0.0,0.0
methotrexate,CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(cc1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,0.0,0.0
cilastatin,CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O,0.0,0.0
STAT3-inhibitor-VI,Cc1ccc(cc1)S(=O)(=O)OCC(=O)Nc1ccc(C(O)=O)c(O)c1,0.0,0.0
enprofylline,CCCn1c2nc[nH]c2c(=O)[nH]c1=O,0.0,0.0
fidaxomicin,"CC[C@H]1\C=C(C)\[C@@H](O)C\C=C\C=C(CO[C@@H]2O[C@H](C)[C@@H](OC(=O)c3c(O)c(Cl)c(O)c(Cl)c3CC)[C@H](O)[C@@H]2OC)\C(=O)O[C@@H](C\C=C(/C)\C=C(C)\[C@@H]1O[C@@H]1OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]1O)[C@@H](C)O |c:3,11,47,50,t:9|",0.0,0.0
T-0156,COC(=O)c1c(-c2cc(OC)c(OC)c(OC)c2)c2ccnc(OCc3ncccn3)c2c(=O)n1Cc1ccnc(C)c1,0.0,0.0
dianhydrogalactitol,O[C@@H]([C@@H](O)[C@H]1CO1)[C@@H]1CO1,0.0,0.0
avobenzone,COc1ccc(cc1)C(=O)C=C(O)c1ccc(cc1)C(C)(C)C,0.0,0.0
firocoxib,CC1(C)OC(=O)C(OCC2CC2)=C1c1ccc(cc1)S(C)(=O)=O |c:12|,0.0,0.0
midafotel,OC(=O)[C@H]1CN(C\C=C\P(O)(O)=O)CCN1,0.0,0.0
isoguvacine,OC(=O)C1=CCNCC1 |t:3|,0.0,0.0
BYK-204165,Cn1cccc1\C=C1/C(=O)NC(=O)c2ccccc12,0.0,0.0
dapivirine,Cc1cc(C)c(Nc2ccnc(Nc3ccc(cc3)C#N)n2)c(C)c1,0.0,0.0
sulfametopyrazine,COc1nccnc1NS(=O)(=O)c1ccc(N)cc1,0.0,0.0
GDC-0941,CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)-c2cccc3n[nH]cc23)CC1,0.0,0.0
Proxyphylline,"C[C@@H](O)Cn1cnc2n(C)c(=O)n(C)c(=O)c12 |&1:1,r|",0.0,0.0
TC-I-15,CC1(C)SCN([C@@H]1C(=O)N[C@@H](CNC(=O)NCc1ccccc1)C(O)=O)S(=O)(=O)c1ccccc1,0.0,0.0
mesulergine,CN(C)S(=O)(=O)N[C@H]1C[C@H]2[C@@H](Cc3cn(C)c4cccc2c34)N(C)C1,0.0,0.0
curcumol,CC(C)[C@@H]1C[C@@]23O[C@]1(O)CC(=C)[C@@H]2CC[C@@H]3C,0.0,0.0
ZCL-278,Cc1cc(C)nc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)COc3ccc(Br)cc3Cl)cc2)n1,0.0,0.0
SNC-80,CCN(CC)C(=O)c1ccc(cc1)[C@@H](N1C[C@@H](C)N(CC=C)C[C@@H]1C)c1cccc(OC)c1,0.0,0.0
GW-843682X,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(N)=O)c2cc1OC,0.0,0.0
ethoxzolamide,CCOc1ccc2nc(sc2c1)S(N)(=O)=O,0.0,0.0
flumecinol,"CC[C@@](O)(c1ccccc1)c1cccc(c1)C(F)(F)F |&1:2,r|",0.0,0.0
troclosene,Cln1c(=O)[nH]c(=O)n(Cl)c1=O,0.0,0.0
paricalcitol,C[C@H](\C=C\[C@H](C)C(C)(C)O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C[C@H](O)C1,0.0,0.0
2-TEDC,Oc1ccc(\C=C(/C#N)C(=O)OCCc2cccs2)cc1O,0.0,0.0
elacytarabine,CCCCCCCC\C=C\CCCCCCCC(=O)OC[C@H]1O[C@H]([C@@H](O)[C@@H]1O)n1ccc(N)nc1=O,0.0,0.0
mosapride,CCOc1cc(N)c(Cl)cc1C(=O)NC[C@H]1CN(Cc2ccc(F)cc2)CCO1 |&1:15|,0.0,0.0
A0001,"CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@@](C)(O)CCC1=C(C)C(=O)C(C)=C(C)C1=O |c:21,t:27|",0.0,0.0
rabeprazole,COCCCOc1ccnc(C[S@@](=O)c2nc3ccccc3[nH]2)c1C |r|,0.0,0.0
unbs-5162,CN(C)CCN1C(=O)c2cccc3cc(NC(N)=O)cc(C1=O)c23,0.0,0.0
carbamazepine,NC(=O)N1c2ccccc2C=Cc2ccccc12 |c:11|,0.0,0.0
quazinone,CC1N2Cc3c(Cl)cccc3NC2=NC1=O |c:14|,0.0,0.0
pinanediol,CC1(C)[C@H]2C[C@@H]1[C@](C)(O)[C@H](O)C2,0.0,0.0
T-025,CNc1nc(NCc2ncccn2)c2c(c[nH]c2n1)-c1ccc2ncccc2c1,0.0,0.0
sulfachlorpyridazine,Nc1ccc(cc1)S(=O)(=O)Nc1ccc(Cl)nn1,0.0,0.0
pipemidic-acid,CCn1cc(C(O)=O)c(=O)c2cnc(nc12)N1CCNCC1,0.0,0.0
tropesin,"COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)OC[C@@H](C(O)=O)c3ccccc3)c2c1 |&1:24,r|",0.0,0.0
buclizine,CC(C)(C)c1ccc(CN2CCN(CC2)[C@@H](c2ccccc2)c2ccc(Cl)cc2)cc1 |&1:15|,0.0,0.0
"4-phenyl-1,2,3,4-tetrahydroisoquinoline","C1NCc2ccccc2[C@@H]1c1ccccc1 |&1:9,r|",0.0,0.0
BC-11,NC(=N)SCc1ccc(cc1)B(O)O,0.0,0.0
TW-37,CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(cc2)S(=O)(=O)c2ccccc2C(C)(C)C)c(O)c(O)c1O,0.0,0.0
tolperisone,C[C@@H](CN1CCCCC1)C(=O)c1ccc(C)cc1 |r|,0.0,0.0
forskolin,CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C,0.0,0.0
freselestat,CC(C)[C@@H](NC(=O)Cn1c(ncc(N)c1=O)-c1ccccc1)[C@@H](O)c1nnc(o1)C(C)(C)C,0.0,0.0
AB-423,CC[C@@H](C)NS(=O)(=O)c1ccc(F)c(c1)C(=O)Nc1ccc(F)c(F)c1,0.0,0.0
alizapride,"COc1cc2[nH]nnc2cc1C(=O)NC[C@H]1CCCN1CC=C |&1:15,r|",0.0,0.0
2-PMDQ,"O=C1Nc2ccccc2C2=N[C@@H](CN3CCN(CC3)c3ccccc3)CN12 |&1:11,r,t:10|",0.0,0.0
asapiprant,CC(C)Oc1ccc(cc1)S(=O)(=O)N1CCN(CC1)c1ccc(-c2ncco2)c(OCC(O)=O)c1,0.0,0.0
PF-3274167,COCc1nnc(N2CC(C2)Oc2ccc(F)cc2Cl)n1-c1ccc(OC)nc1,0.0,0.0
MY-5445,Clc1cccc(Nc2nnc(-c3ccccc3)c3ccccc23)c1,0.0,0.0
ombitasvir,COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)Nc1ccc(cc1)[C@@H]1CC[C@H](N1c1ccc(cc1)C(C)(C)C)c1ccc(NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)OC)C(C)C)cc1,0.0,0.0
gabapentin-enacarbil,"CC(C)C(=O)O[C@@H](C)OC(=O)NCC1(CC(O)=O)CCCCC1 |&1:6,r|",0.0,0.0
cidofovir,Nc1ccn(C[C@@H](CO)OCP(O)(O)=O)c(=O)n1,0.0,0.0
NS-19504,Nc1ncc(Cc2ccc(Br)cc2)s1,0.0,0.0
brinzolamide,CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(cc12)S(N)(=O)=O,0.0,0.0
SBI-115,CCS(=O)(=O)c1ncc(Cl)c(n1)C(=O)Oc1cccc(C)c1,0.0,0.0
cafestol,C[C@@]12CCc3occc3[C@H]1CC[C@@]13C[C@@H](CC[C@@H]21)[C@@](O)(CO)C3,0.0,0.0
fiacitabine,Nc1nc(=O)n(cc1I)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F,0.0,0.0
benzydamine,CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12,0.0,0.0
E7046,C[C@H](NC(=O)c1c(nn(C)c1Oc1cccc(c1)C(F)(F)F)C(F)F)c1ccc(cc1)C(O)=O,0.0,0.0
alarelin,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1,0.0,0.0
ibuprofen-(S),CC(C)Cc1ccc(cc1)[C@H](C)C(O)=O,0.0,0.0
clonixin-lysinate,NCCCC[C@H](N)C(O)=O.Cc1c(Cl)cccc1Nc1ncccc1C(O)=O,0.0,0.0
suxibuzone,CCCCC1(COC(=O)CCC(O)=O)C(=O)N(N(C1=O)c1ccccc1)c1ccccc1,0.0,0.0
lasofoxifene,O[C@@H]([C@H](O)C(O)=O)C(O)=O.Oc1ccc2[C@H]([C@H](CCc2c1)c1ccccc1)c1ccc(OCCN2CCCC2)cc1,0.0,0.0
R406,COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)Nc4n3)n2)cc(OC)c1OC,0.0,0.0
arsanilic-acid,Nc1ccc(cc1)[As](O)(O)=O,0.0,0.0
erythromycin-ethylsuccinate,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,0.0,0.0
lauric-diethanolamide,CCCCCCCCCCCC(=O)N(CCO)CCO,0.0,0.0
cholesterol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C |t:14|,0.0,0.0
antimony-potassium,[H][C@]12O[SbH]3(OC1=O)OC(=O)[C@]([H])(O3)[C@@]1([H])O[SbH]3(OC(=O)[C@]2([H])O3)OC1=O |r|,0.0,0.0
BAZ2-ICR,Cn1cc(CCn2cnc(-c3cnn(C)c3)c2-c2ccc(cc2)C#N)cn1,0.0,0.0
TAK-960,COc1cc(C(=O)NC2CCN(C)CC2)c(F)cc1Nc1ncc2N(C)C(=O)C(F)(F)CN(C3CCCC3)c2n1,0.0,0.0
cinromide,CCNC(=O)\C=C\c1cccc(Br)c1,0.0,0.0
temoporfin,Oc1cccc(c1)-c1c2CCc([nH]2)c(-c2cccc(O)c2)c2ccc([nH]2)c(-c2cccc(O)c2)c2ccc(n2)c(-c2cccc(O)c2)c2ccc1n2,0.0,0.0
allylthiourea,NC(=S)NCC=C,0.0,0.0
GDC-0927,CC1=C([C@@H](Oc2ccc(O)cc12)c1ccc(OCCN2CC(CF)C2)cc1)c1cccc(O)c1 |t:1|,0.0,0.0
dimaprit,CN(C)CCCSC(N)=N,0.0,0.0
palosuran,Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1,0.0,0.0
GGTI-298,COC(=O)[C@H](CC(C)C)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1cccc2ccccc12,0.0,0.0
folic-acid,Nc1nc(=O)c2nc(CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)cnc2[nH]1,0.0,0.0
benzyldimethyloctylammonium,CCCCCCCC[N+](C)(C)Cc1ccccc1,0.0,0.0
gossypol,CC(C)c1c(O)c(O)c(C=O)c2c(O)c(c(C)cc12)-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O,0.0,0.0
succinobucol,CC(C)(C)c1cc(SC(C)(C)Sc2cc(c(OC(=O)CCC(O)=O)c(c2)C(C)(C)C)C(C)(C)C)cc(c1O)C(C)(C)C,0.0,0.0
aklomide,NC(=O)c1ccc(cc1Cl)[N+]([O-])=O,0.0,0.0
EVP4593,Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1,0.0,0.0
azodicarbonamide,NC(=O)\N=N\C(N)=O,0.0,0.0
DCC-2618,Cn1cc(cn1)-c1cc(Oc2cc(F)c(NC(=O)C3(CC3)C(=O)Nc3ccccc3)cc2F)ccn1,0.0,0.0
sincalide,CSCC[C@H](NC(=O)[C@H](Cc1ccc(OS(O)(=O)=O)cc1)NC(=O)[C@@H](N)CC(O)=O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,0.0,0.0
17-hydroxyprogesterone-caproate,CCCCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O |t:15|,0.0,0.0
VU0240551,Cc1csc(NC(=O)CSc2ccc(nn2)-c2ccccc2)n1,0.0,0.0
hypoxanthine,O=c1nc[nH]c2nc[nH]c12,0.0,0.0
necrostatin-1,CN1C(=S)N[C@@H](Cc2c[nH]c3ccccc23)C1=O |r|,0.0,0.0
nateglinide,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](Cc1ccccc1)C(O)=O,0.0,0.0
emoxipin,CCc1nc(C)ccc1O,0.0,0.0
XMD17-109,CCOc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C3CCCC3)c2n1)C(=O)N1CCC(CC1)N1CCN(C)CC1,0.0,0.0
SB-743921,CC(C)[C@@H](N(CCCN)C(=O)c1ccc(C)cc1)c1oc2cc(Cl)ccc2c(=O)c1Cc1ccccc1,0.0,0.0
exenatide,[H]N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(N)=O |r|,0.0,0.0
biapenem,"C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(SC3Cn4cnc[n+]4C3)=C(N2C1=O)C(O)=O |a:1,3,4,5,&1:9,c:18|",0.0,0.0
macelignan,COc1cc(C[C@H](C)[C@H](C)Cc2ccc3OCOc3c2)ccc1O,0.0,0.0
ABT-239,C[C@@H]1CCCN1CCc1cc2cc(ccc2o1)-c1ccc(cc1)C#N,0.0,0.0
suprofen,"C[C@@H](C(O)=O)c1ccc(cc1)C(=O)c1cccs1 |&1:1,r|",0.0,0.0
febuprol,"CCCCOC[C@@H](O)COc1ccccc1 |&1:6,r|",0.0,0.0
macitentan,CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,0.0,0.0
delta-tocotrienol,CC(C)=CCC\C(C)=C\CC\C(C)=C\CC[C@]1(C)CCc2cc(O)cc(C)c2O1,0.0,0.0
5-octanoylsalicylic-acid,CCCCCCCC(=O)c1ccc(O)c(c1)C(O)=O,0.0,0.0
perindoprilat,CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(O)=O)C(O)=O,0.0,0.0
eptifibatide,NC(=N)NCCCC[C@@H]1NC(=O)CCSSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O)C(N)=O,0.0,0.0
monobenzone,Oc1ccc(OCc2ccccc2)cc1,0.0,0.0
EX-527,"NC(=O)[C@H]1CCCc2c1[nH]c1ccc(Cl)cc21 |&1:3,r|",0.0,0.0
verbascoside,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO)[C@H]2OC(=O)\C=C\c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O,0.0,0.0
tetrahydrozoline,"C1CN=C(N1)[C@H]1CCCc2ccccc12 |&1:5,c:2|",0.0,0.0
moxonidine,COc1nc(C)nc(Cl)c1NC1=NCCN1 |t:12|,0.0,0.0
phenylpiracetam,"NC(=O)CN1C[C@@H](CC1=O)c1ccccc1 |&1:6,r|",0.0,0.0
levodropropizine,OC[C@@H](O)CN1CCN(CC1)c1ccccc1,0.0,0.0
phenelzine,NNCCc1ccccc1,0.0,0.0
myricitrin,C[C@@H]1O[C@@H](Oc2c(oc3cc(O)cc(O)c3c2=O)-c2cc(O)c(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O,0.0,0.0
YS-201,"CCOC(=O)C1=C(C)NC(C)=C([C@@H]1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN1CCCCC1 |&1:12,r,c:5,10|",0.0,0.0
ivacaftor,CC(C)(C)c1cc(c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O)C(C)(C)C,0.0,0.0
L-690330,CC(Oc1ccc(O)cc1)(P(O)(O)=O)P(O)(O)=O,0.0,0.0
PU-H71,CC(C)NCCCn1c(Sc2cc3OCOc3cc2I)nc2c(N)ncnc12,0.0,0.0
cyclopentolate,CN(C)CCOC(=O)[C@@H](c1ccccc1)C1(O)CCCC1 |&1:8|,0.0,0.0
BHQ,CC(C)(C)c1cc(O)c(cc1O)C(C)(C)C,0.0,0.0
MK-2461,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(cc3c(=O)c2c1)-c1cnn(C)c1,0.0,0.0
dichloroacetate,[Na].OC(=O)C(Cl)Cl,0.0,0.0
naltriben,Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](Oc1c24)c1oc2ccccc2c1C[C@@]35O,0.0,0.0
eflornithine,NCCCC(N)(C(F)F)C(O)=O |&1:4|,0.0,0.0
tropicamide,"CCN(Cc1ccncc1)C(=O)[C@@H](CO)c1ccccc1 |&1:12,r|",0.0,0.0
tecastemizole,Fc1ccc(Cn2c(NC3CCNCC3)nc3ccccc23)cc1,0.0,0.0
SKI-II,Oc1ccc(Nc2nc(cs2)-c2ccc(Cl)cc2)cc1,0.0,0.0
pilaralisib,COc1ccc(Cl)c(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(NC(=O)C(C)(C)N)c2)c1,0.0,0.0
EC-23,CC1(C)CCC(C)(C)c2cc(ccc12)C#Cc1ccc(cc1)C(O)=O,0.0,0.0
nefiracetam,Cc1cccc(C)c1NC(=O)CN1CCCC1=O,0.0,0.0
JIB04,Clc1ccc(N\N=C(/c2ccccc2)c2ccccn2)nc1,0.0,0.0
LB-100,"CN1CCN(CC1)C(=O)[C@@H]1[C@H]2CC[C@H](O2)[C@@H]1C(O)=O |&1:10,13,&2:15,&3:9|",0.0,0.0
dithranol,Oc1cccc2cc3cccc(O)c3c(O)c12,0.0,0.0
obatoclax,"COC1=CC(=N\C1=C/c1[nH]c(C)cc1C)c1cc2ccccc2[nH]1 |c:4,t:2|",0.0,0.0
LXS196,CC1(N)CCN(CC1)c1cccnc1NC(=O)c1nc(cnc1N)-c1ncccc1C(F)(F)F,0.0,0.0
proscillaridin-A,C[C@@H]1O[C@@H](O[C@H]2CC[C@]3(C)[C@H]4CC[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CCC3=C2)c2ccc(=O)oc2)[C@H](O)[C@H](O)[C@H]1O |c:26|,0.0,0.0
AMG-487-(+/-),"CCOc1ccc(cc1)-n1c(nc2ncccc2c1=O)[C@@H](C)N(Cc1cccnc1)C(=O)Cc1ccc(OC(F)(F)F)cc1 |&1:20,r|",0.0,0.0
carsalam,O=c1[nH]c(=O)c2ccccc2o1,0.0,0.0
HQK-1001,CCC(C)(C)C(O)=O,0.0,0.0
nimorazole,[O-][N+](=O)c1cncn1CCN1CCOCC1,0.0,0.0
CC-223,CO[C@H]1CC[C@@H](CC1)N1C(=O)CNc2ncc(nc12)-c1ccc(nc1)C(C)(C)O |r|,0.0,0.0
PIK-75,CN(\N=C\c1cnc2ccc(Br)cn12)S(=O)(=O)c1cc(ccc1C)[N+]([O-])=O,0.0,0.0
chlorotrianisene,COc1ccc(cc1)C(Cl)=C(c1ccc(OC)cc1)c1ccc(OC)cc1,0.0,0.0
myricetin,Oc1cc(O)c2c(c1)oc(-c1cc(O)c(O)c(O)c1)c(O)c2=O,0.0,0.0
CPSI-1306-(+/-),"Fc1ccc(C2=NO[C@@H](CC(=O)N3CCOCC3)C2)c(F)c1 |&1:8,r,t:5|",0.0,0.0
mitoflaxone,OC(=O)Cc1cccc2c1oc(cc2=O)-c1ccccc1,0.0,0.0
merbarone,Oc1[nH]c(=S)[nH]c(=O)c1C(=O)Nc1ccccc1,0.0,0.0
desoxycorticosterone-pivalate,CC(C)(C)C(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C |t:17|,0.0,0.0
topilutamide,"C[C@](O)(CNC(=O)C(F)(F)F)C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+]([O-])=O |&1:1,r|",0.0,0.0
soblidotin,[H][C@]1(CCCN1C(=O)C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C)[C@H](OC)[C@@H](C)C(=O)NCCc1ccccc1,0.0,0.0
vanoxerine,Fc1ccc(cc1)C(OCCN1CCN(CCCc2ccccc2)CC1)c1ccc(F)cc1,0.0,0.0
etofylline-clofibrate,Cn1c2ncn(CCOC(=O)C(C)(C)Oc3ccc(Cl)cc3)c2c(=O)n(C)c1=O,0.0,0.0
sacubitril,CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC(O)=O,0.0,0.0
monostearin,"CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)CO |&1:21,r|",0.0,0.0
delgocitinib,C[C@H]1CN(C(=O)CC#N)[C@]11CCN(C1)c1ncnc2[nH]ccc12,0.0,0.0
L-quisqualic-acid,N[C@@H](Cn1oc(=O)[nH]c1=O)C(O)=O,0.0,0.0
hesperadin,CCS(=O)(=O)Nc1ccc2NC(=O)\C(=C(/Nc3ccc(CN4CCCCC4)cc3)c3ccccc3)c2c1,0.0,0.0
imipramine,CN(C)CCCN1c2ccccc2CCc2ccccc12,0.0,0.0
C-1,O=S(=O)(N1CCNCC1)c1cccc2cnccc12,0.0,0.0
AS-252424,Oc1cc(F)ccc1-c1ccc(\C=C2/SC(=O)NC2=O)o1,0.0,0.0
otenzepad,"CCN(CC)C[C@H]1CCCCN1CC(=O)N1c2ccccc2C(=O)Nc2cccnc12 |&1:6,r|",0.0,0.0
pentostatin,OC[C@H]1O[C@H](C[C@@H]1O)n1cnc2[C@H](O)CN=CNc12 |c:16|,0.0,0.0
pamabrom,CC(C)(N)CO.Cn1c2nc(Br)[nH]c2c(=O)n(C)c1=O,0.0,0.0
dextromethorphan,COc1ccc2C[C@H]3[C@H]4CCCC[C@@]4(CCN3C)c2c1,0.0,0.0
5-hydroxydecanoic-acid,CCCCC[C@@H](O)CCCC(O)=O |&1:5|,0.0,0.0
cefpodoxime,"COCC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=N/OC)\c1csc(N)n1)C2=O)C(=O)O[C@@H](C)OC(=O)OC(C)C |a:6,9,&1:28,t:3|",0.0,0.0
PD-166793,CC(C)[C@H](NS(=O)(=O)c1ccc(cc1)-c1ccc(Br)cc1)C(O)=O,0.0,0.0
bismuth(III)-trifluoromethanesulfonate,[Bi].OS(=O)(=O)C(F)(F)F.OS(=O)(=O)C(F)(F)F.OS(=O)(=O)C(F)(F)F,0.0,0.0
carmofur,CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O,0.0,0.0
SB-939,CCCCc1nc2cc(\C=C\C(=O)NO)ccc2n1CCN(CC)CC,0.0,0.0
mofegiline,NC\C(CCc1ccc(F)cc1)=C\F,0.0,0.0
psoralen,O=c1ccc2cc3ccoc3cc2o1,0.0,0.0
NS-8593,C1C[C@@H](Nc2nc3ccccc3[nH]2)c2ccccc2C1,0.0,0.0
azilsartan,CCOc1nc2cccc(C(O)=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nc(=O)o[nH]1,0.0,0.0
pyritinol,Cc1ncc(CSSCc2cnc(C)c(O)c2CO)c(CO)c1O,0.0,0.0
veliflapon,OC(=O)[C@H](C1CCCC1)c1ccc(OCc2ccc3ccccc3n2)cc1,0.0,0.0
asivatrep,CCCc1nc(ccc1\C=C\C(=O)N[C@H](C)c1cc(F)c(NS(C)(=O)=O)c(F)c1)C(F)(F)F,0.0,0.0
adomeglivant,Cc1cc(O[C@@H](CCC(F)(F)F)c2ccc(cc2)C(=O)NCCC(O)=O)cc(C)c1-c1ccc(cc1)C(C)(C)C,0.0,0.0
talniflumate,"FC(F)(F)c1cccc(Nc2ncccc2C(=O)O[C@H]2OC(=O)c3ccccc23)c1 |&1:19,r|",0.0,0.0
GSK-3-inhibitor-IX,O\N=C1/C(/Nc2ccccc/12)=C1/C(=O)Nc2cc(Br)ccc12,0.0,0.0
BRD9876,CC(C)(C)c1ccc2cc(C#N)c(cc2c1)C#N,0.0,0.0
TC-G-1004,COC1CCN(CC1)c1cccc(n1)-c1cc(NC(C)=O)nc(n1)-n1nc(C)cc1C,0.0,0.0
ACY-1215,ONC(=O)CCCCCCNC(=O)c1cnc(nc1)N(c1ccccc1)c1ccccc1,0.0,0.0
BMS-779788,CC(C)(O)c1cn(c(n1)C(C)(C)c1ccccc1Cl)-c1ccc(cc1)-c1cccc(c1)S(C)(=O)=O,0.0,0.0
epirubicin,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO,0.0,0.0
drofenine,CCN(CC)CCOC(=O)[C@@H](C1CCCCC1)c1ccccc1 |&1:10|,0.0,0.0
procyanidin-B-2,O[C@H]1Cc2c(O)cc(O)c([C@@H]3[C@@H](O)[C@H](Oc4cc(O)cc(O)c34)c3ccc(O)c(O)c3)c2O[C@@H]1c1ccc(O)c(O)c1,0.0,0.0
AA-29504,CCOC(=O)Nc1ccc(NCc2c(C)cc(C)cc2C)cc1N,0.0,0.0
T-0901317,OC(c1ccc(cc1)N(CC(F)(F)F)S(=O)(=O)c1ccccc1)(C(F)(F)F)C(F)(F)F,0.0,0.0
SID-7969543,"CCOC(=O)[C@@H](C)Oc1cccc2c1ccn(CC(=O)Nc1ccc3OCCOc3c1)c2=O |&1:5,r|",0.0,0.0
nuclomedone,"Clc1ccc(C[C@H]2C(=O)N=C3SCCN3C2=O)cc1 |r,t:9|",0.0,0.0
ML130,Cc1ccc(cc1)S(=O)(=O)n1c(N)nc2ccccc12,0.0,0.0
pirenzepine,CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc23)CC1,0.0,0.0
GW-311616,CC(C)[C@H]1[C@H]2[C@@H](CCN2C(=O)\C=C\CN2CCCCC2)N(C1=O)S(C)(=O)=O,0.0,0.0
2-oxopropanoate,OC(=C)C(O)=O,0.0,0.0
L-365260,CN1c2ccccc2C(=N[C@@H](NC(=O)Nc2cccc(C)c2)C1=O)c1ccccc1 |c:9|,0.0,0.0
nifekalant,Cn1c(NCCN(CCO)CCCc2ccc(cc2)[N+]([O-])=O)cc(=O)n(C)c1=O,0.0,0.0
GNF-5,OCCNC(=O)c1cccc(c1)-c1cc(Nc2ccc(OC(F)(F)F)cc2)ncn1,0.0,0.0
fluconazole,OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F,0.0,0.0
TRAM-34,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1cccn1,0.0,0.0
PLX51107,C[C@@H](c1ccccn1)n1cc(-c2ccc(cc2)C(O)=O)c2ncc(cc12)-c1c(C)noc1C,0.0,0.0
JTE-907,CCCCCOc1c(OC)ccc2cc(C(=O)NCc3ccc4OCOc4c3)c(=O)[nH]c12,0.0,0.0
DC-260126,CCCCc1ccc(NS(=O)(=O)c2ccc(F)cc2)cc1,0.0,0.0
SU16f,Cc1[nH]c(\C=C2/C(=O)Nc3cc(ccc23)-c2ccccc2)c(C)c1CCC(O)=O,0.0,0.0
cyproterone-acetate,"CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C)C(C)=O |t:9,12|",0.0,0.0
tiapride,CCN(CC)CCNC(=O)c1cc(ccc1OC)S(C)(=O)=O,0.0,0.0
8-bromo-cGMP,"Nc1nc(=O)c2nc(Br)n([C@@H]3O[C@@H]4CO[P@](O)(=O)O[C@H]4[C@H]3O)c2[nH]1 |a:10,12,19,20,&1:15|",0.0,0.0
naringin-dihydrochalcone,C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2Oc2cc(O)c(C(=O)CCc3ccc(O)cc3)c(O)c2)[C@H](O)[C@H](O)[C@H]1O,0.0,0.0
HA-130,OB(O)c1cccc(COc2ccc(\C=C3/SC(=O)N(Cc4ccc(F)cc4)C3=O)cc2)c1,0.0,0.0
PF-02545920,Cn1cc(c(n1)-c1ccc(OCc2ccc3ccccc3n2)cc1)-c1ccncc1,0.0,0.0
relugolix,CONC(=O)Nc1ccc(cc1)-c1sc2n(Cc3c(F)cccc3F)c(=O)n(-c3ccc(OC)nn3)c(=O)c2c1CN(C)C,0.0,0.0
sacubitrilat,[H]N([C@@H](C[C@@H](C)C(O)=O)Cc1ccc(cc1)-c1ccccc1)C(=O)CCC(O)=O,0.0,0.0
SKF-91488,CN(C)CCCCSC(N)=N,0.0,0.0
LDN193189,C1CN(CCN1)c1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccnc2ccccc12,0.0,0.0
pevonedistat,NS(=O)(=O)OC[C@@H]1C[C@H](C[C@@H]1O)n1ccc2c(N[C@H]3CCc4ccccc34)ncnc12,0.0,0.0
larotrectinib,O[C@H]1CCN(C1)C(=O)Nc1cnn2ccc(nc12)N1CCC[C@@H]1c1cc(F)ccc1F,0.0,0.0
20-HETE,OCCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O,0.0,0.0
CVT-10216,CS(=O)(=O)Nc1ccc(cc1)-c1coc2cc(OCc3cccc(c3)C(O)=O)ccc2c1=O,0.0,0.0
PIT,[O-][N+]1=C(C(=O)c2ccccc12)c1ccccn1 |t:1|,0.0,0.0
BMS-806,COc1ccnc2[nH]cc(C(=O)C(=O)N3CCN(C[C@H]3C)C(=O)c3ccccc3)c12,0.0,0.0
luzindole,CC(=O)NCCc1c(Cc2ccccc2)[nH]c2ccccc12,0.0,0.0
GSK2801,CCCOc1ccn2c(cc(-c3ccccc3S(C)(=O)=O)c2c1)C(C)=O,0.0,0.0
argireline,CSCC[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(C)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O,0.0,0.0
cysteamine,NCCS,0.0,0.0
TC-O-9311,COc1cc(OC)cc(c1)C(=O)NNC(=O)Nc1cccc2ccccc12,0.0,0.0
MK-0812,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](C1)(C(C)C)C(=O)N1CCc2ncc(cc2C1)C(F)(F)F,0.0,0.0
bupivacaine,"CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C |&1:9,r|",0.0,0.0
empagliflozin,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(Cl)c(Cc2ccc(O[C@H]3CCOC3)cc2)c1,0.0,0.0
6-aminochrysene,Nc1cc2c3ccccc3ccc2c2ccccc12,0.0,0.0
NSC-9965,"CO[C@H]1CC=C2CCN3CCC4=C(CC(=O)OC4)[C@]23C1 |t:4,11|",0.0,0.0
triptan,CC(C)C(C)(C)C,0.0,0.0
norvancomycin,[H][C@@]1(C[C@](C)(N)[C@H](O)[C@H](C)O1)O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1Oc1c2Oc3ccc(cc3Cl)[C@@H](O)[C@@H](NC(=O)[C@H](N)CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@]3([H])c(c2)cc1Oc1ccc(cc1Cl)[C@@H](O)[C@]1([H])NC(=O)[C@]([H])(NC3=O)c2ccc(O)c(c2)-c2c(O)cc(O)cc2[C@]([H])(NC1=O)C(O)=O,0.0,0.0
EGF816,CN(C)C\C=C\C(=O)N1CCCC[C@H](C1)n1c(NC(=O)c2ccnc(C)c2)nc2cccc(Cl)c12,0.0,0.0
ifosfamide,ClCCN[P@@]1(=O)OCCCN1CCCl |r|,0.0,0.0
quinethazone,"CC[C@H]1NC(=O)c2cc(c(Cl)cc2N1)S(N)(=O)=O |&1:2,r|",0.0,0.0
BIBR-1532,C\C(=C/C(=O)Nc1ccccc1C(O)=O)c1ccc2ccccc2c1,0.0,0.0
RAD140,[H][C@@](C)(O)[C@@]([H])(Nc1ccc(C#N)c(Cl)c1C)c1nnc(o1)-c1ccc(cc1)C#N,0.0,0.0
phenyl-salicylate,Oc1ccccc1C(=O)Oc1ccccc1,0.0,0.0
setiptiline,CN1CCC2=C(C1)c1ccccc1Cc1ccccc21 |c:4|,0.0,0.0
veledimex,CCC[C@@H](N(NC(=O)c1cccc(OC)c1CC)C(=O)c1cc(C)cc(C)c1)C(C)(C)C,0.0,0.0
oxprenolol,CC(C)NC[C@@H](O)COc1ccccc1OCC=C |&1:5|,0.0,0.0
GS-39783,CSc1nc(NC2CCCC2)c(c(NC2CCCC2)n1)[N+]([O-])=O,0.0,0.0
picrotin,"CC(C)(O)[C@H]1[C@H]2OC(=O)[C@@H]1[C@@]1(O)C[C@H]3O[C@]33C(=O)O[C@@H]2[C@@]13C |&1:4,&2:5,&3:9,&4:10,&5:13,&6:15,&7:19,&8:20,r|",0.0,0.0
nifenalol,"CC(C)NC[C@@H](O)c1ccc(cc1)[N+]([O-])=O |&1:5,r|",0.0,0.0
CP-99994,COc1ccccc1CN[C@H]1CCCN[C@H]1c1ccccc1,0.0,0.0
apricitabine,Nc1ccn([C@H]2CO[C@@H](CO)S2)c(=O)n1,0.0,0.0
ecabapide,CNC(=O)c1cccc(NCC(=O)NCCc2ccc(OC)c(OC)c2)c1,0.0,0.0
GSK3117391,ONC(=O)CCc1ccc(CN[C@@H](C2CCCCC2)C(=O)OC2CCCC2)cn1,0.0,0.0
tetracaine,CCCCNc1ccc(cc1)C(=O)OCCN(C)C,0.0,0.0
PD-123319,CN(C)c1ccc(Cn2cnc3CN([C@@H](Cc23)C(O)=O)C(=O)C(c2ccccc2)c2ccccc2)cc1C,0.0,0.0
CS-110266,C1CCN(CC1)C1(CCCCC1)c1cc2ccccc2s1,0.0,0.0
linagliptin,CC#CCn1c(nc2n(C)c(=O)n(Cc3nc(C)c4ccccc4n3)c(=O)c12)N1CCC[C@@H](N)C1,0.0,0.0
mepyramine,COc1ccc(CN(CCN(C)C)c2ccccn2)cc1,0.0,0.0
AMG900,Cc1csc(c1)-c1nnc(Nc2ccc(Oc3ncccc3-c3ccnc(N)n3)cc2)c2ccccc12,0.0,0.0
beclabuvir,COc1ccc2-c3c(C4CCCCC4)c4ccc(cc4n3C[C@]3(C[C@H]3c2c1)C(=O)N1[C@H]2CC[C@@H]1CN(C)C2)C(=O)NS(=O)(=O)N(C)C |THB:27:29:31.32:34.35.37|,0.0,0.0
AZD5582,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]1[C@@H](Cc2ccccc12)OCC#CC#CCO[C@@H]1Cc2ccccc2[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC)C1CCCCC1,0.0,0.0
leucylleucine-methyl-ester,COC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C,0.0,0.0
thonzylamine,COc1ccc(CN(CCN(C)C)c2ncccn2)cc1,0.0,0.0
raltegravir,Cc1nnc(o1)C(=O)NC(C)(C)c1nc(C(=O)NCc2ccc(F)cc2)c(O)c(=O)n1C,0.0,0.0
hydroflumethiazide,NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1C(F)(F)F,0.0,0.0
vanitiolide,COc1cc(ccc1O)C(=S)N1CCOCC1,0.0,0.0
ornipressin,[H][C@@]1(Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O,0.0,0.0
K-Ras(G12C)-inhibitor-12,Oc1cc(Cl)c(I)cc1NCC(=O)N1CCN(CC1)C(=O)C=C,0.0,0.0
apafant,Cc1nnc2CN=C(c3cc(CCC(=O)N4CCOCC4)sc3-n12)c1ccccc1Cl |c:6|,0.0,0.0
DFB,Fc1cccc(\C=N\N=C\c2cccc(F)c2)c1,0.0,0.0
vinflunine,CC[C@@]12C=CCN3CC[C@@]4([C@H]13)[C@@H](N(C)c1cc(OC)c(cc41)[C@]1(C[C@@H]3C[C@H](C[N@@](C3)CCc3c1[nH]c1ccccc31)C(C)(F)F)C(=O)OC)[C@](O)([C@@H]2OC(C)=O)C(=O)OC |c:3|,0.0,0.0
pimozide,Fc1ccc(cc1)C(CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O)c1ccc(F)cc1,0.0,0.0
O4I1,COc1ccc(COc2ccc(CC#N)cc2)cc1,0.0,0.0
clemizole,Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc23)cc1,0.0,0.0
paliperidone,"Cc1nc2[C@@H](O)CCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12 |&1:4,r|",0.0,0.0
gastrodin,OC[C@H]1O[C@@H](Oc2ccc(CO)cc2)[C@H](O)[C@@H](O)[C@@H]1O,0.0,0.0
"2,3-DCPE",OCCNCCCOc1cccc(Cl)c1Cl,0.0,0.0
levamlodipine,"CCOC(=O)C1=C(COCCN)NC(C)=C([C@@H]1c1ccccc1Cl)C(=O)OC |c:5,14|",0.0,0.0
trimethoquinol,COc1cc(C[C@H]2NCCc3cc(O)c(O)cc23)cc(OC)c1OC |&1:6|,0.0,0.0
glutathione,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O,0.0,0.0
TC-A-2317,C[C@@H](CCCC(C)(C)O)Nc1nc(Nc2cc(C)n[nH]2)cc(C)c1C#N |&1:1|,0.0,0.0
mavoglurant,COC(=O)N1CC[C@@H]2[C@H]1CCC[C@@]2(O)C#Cc1cccc(C)c1,0.0,0.0
polyinosine,"O[C@H]1[C@@H](COP(O)(O)=O)O[C@@H]([C@@H]1O)n1cnc2c1[nH]cnc2=O |&1:1,&2:2,&3:10,&4:11,r|",0.0,0.0
prilocaine,"CCCN[C@@H](C)C(=O)Nc1ccccc1C |&1:4,r|",0.0,0.0
atracurium,"COc1ccc(C[C@H]2c3cc(OC)c(OC)cc3CC[N@@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCc3cc(OC)c(OC)cc3[C@@H]2Cc2ccc(OC)c(OC)c2)cc1OC |&1:7,&2:20,&3:37,&4:51|",0.0,0.0
tabimorelin,CNC(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc1ccc2ccccc2c1)N(C)C(=O)\C=C\CC(C)(C)N,0.0,0.0
PF-4800567,Nc1ncnc2n(nc(COc3cccc(Cl)c3)c12)C1CCOCC1,0.0,0.0
stobadine,CN1CC[C@H]2Nc3ccc(C)cc3[C@H]2C1,0.0,0.0
velaresol,OC(=O)CCCCOc1cccc(O)c1C=O,0.0,0.0
megestrol-acetate,"CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O |t:9,12|",0.0,0.0
SB-705498,FC(F)(F)c1ccc(nc1)N1CC[C@H](C1)NC(=O)Nc1ccccc1Br,0.0,0.0
LCQ908,OC(=O)C[C@H]1CC[C@@H](CC1)c1ccc(cc1)-c1ccc(Nc2ccc(nc2)C(F)(F)F)cn1 |r|,0.0,0.0
DS2-(806622),Clc1ccc(cc1)C(=O)Nc1c(nc2ccccn12)-c1cccs1,0.0,0.0
CKD-712,Oc1cc2CCN[C@@H](Cc3cccc4ccccc34)c2cc1O |&1:7|,0.0,0.0
BIMU-8,"CC(C)n1c2ccccc2n(C(=O)N[C@@H]2C[C@@H]3CC[C@H](C2)N3C)c1=O |&1:14,16,19|",0.0,0.0
4-propylbenzoic-acid,CCCc1ccc(cc1)C(O)=O,0.0,0.0
guacetisal,COc1ccccc1OC(=O)c1ccccc1OC(C)=O,0.0,0.0
zometapine,Cc1nn(C)c2NCCN=C(c12)c1cccc(Cl)c1 |c:9|,0.0,0.0
BTB1,[O-][N+](=O)c1cc(Cl)ccc1S(=O)(=O)c1ccccc1,0.0,0.0
hydroxyamphetamine,C[C@@H](N)Cc1ccc(O)cc1 |&1:1|,0.0,0.0
lemborexant,Cc1ncc(OC[C@]2(C[C@H]2C(=O)Nc2ccc(F)cn2)c2cccc(F)c2)c(C)n1,0.0,0.0
JDTic,CC(C)[C@@H](CN1CC[C@](C)([C@@H](C)C1)c1cccc(O)c1)NC(=O)[C@H]1Cc2ccc(O)cc2CN1,0.0,0.0
VER-49009,CCNC(=O)c1[nH]nc(c1-c1ccc(OC)cc1)-c1cc(Cl)c(O)cc1O,0.0,0.0
ftorafur,Fc1cn([C@H]2CCCO2)c(=O)[nH]c1=O,0.0,0.0
SNX-5422,CC1(C)Cc2c(c(nn2-c2ccc(C(N)=O)c(N[C@H]3CC[C@@H](CC3)OC(=O)CN)c2)C(F)(F)F)C(=O)C1 |r|,0.0,0.0
TC-G-1005,Cc1ccc(C)c(Oc2ccncc2C(=O)N2CCN(C3CC3)c3ccccc23)c1,0.0,0.0
fenipentol,"CCCC[C@@H](O)c1ccccc1 |&1:4,r|",0.0,0.0
benzoxiquine,O=C(Oc1cccc2cccnc12)c1ccccc1,0.0,0.0
dapagliflozin,CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1,0.0,0.0
menatetrenone,CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CC1=C(C)C(=O)c2ccccc2C1=O |c:20|,0.0,0.0
MJ-15,Cc1c(nn(c1-c1ccc(Cl)cc1)-c1ccc(Cl)cc1Cl)C(=O)NCc1cccnc1,0.0,0.0
CHIR-99021,Cc1c[nH]c(n1)-c1cnc(NCCNc2ccc(cn2)C#N)nc1-c1ccc(Cl)cc1Cl,0.0,0.0
sancycline,"[H][C@@]12Cc3cccc(O)c3C(=O)[C@@H]1C(=O)[C@]1(O)C(=O)[C@H](C(N)=O)C(=O)[C@@H](N(C)C)[C@]1([H])C2 |&1:19,&2:12|",0.0,0.0
10-deacetylbaccatin,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]1(C)[C@@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](O)C(C)=C([C@@H](O)C1=O)C2(C)C |t:33|,0.0,0.0
emetine,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc12,0.0,0.0
SKF-77434,Oc1cc2CCN(CC=C)C[C@@H](c3ccccc3)c2cc1O |&1:11|,0.0,0.0
guanosine,Nc1nc(=O)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2[nH]1,0.0,0.0
sulfacarbamide,NC(=O)NS(=O)(=O)c1ccc(N)cc1,0.0,0.0
AZD9272,Fc1ccc(nc1)-c1noc(n1)-c1cc(F)cc(c1)C#N,0.0,0.0
5-BDBD,Brc1cccc(c1)C1=NCC(=O)Nc2c1oc1ccccc21 |t:8|,0.0,0.0
temefos,COP(=S)(OC)Oc1ccc(Sc2ccc(OP(=S)(OC)OC)cc2)cc1,0.0,0.0
barasertib-HQPA,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)n[nH]3)ncnc2c1,0.0,0.0
PRN1371,CNc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)c(=O)n(CCCN3CCN(CC3)C(=O)C=C)c2n1,0.0,0.0
efaproxiral,Cc1cc(C)cc(NC(=O)Cc2ccc(OC(C)(C)C(O)=O)cc2)c1,0.0,0.0
algestone-acetophenide,CC(=O)[C@@]12O[C@@](C)(O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]21C)c1ccccc1 |t:15|,0.0,0.0
flucytosine,Nc1nc(=O)[nH]cc1F,0.0,0.0
AC-186,Oc1ccc(cc1)C1(CCC(F)(F)CC1)c1ccccc1F,0.0,0.0
idalopirdine,FC(F)C(F)(F)COc1cccc(CNCCc2c[nH]c3cc(F)ccc23)c1,0.0,0.0
RLX,O=c1n2CCCCCc2nc2ccccc12,0.0,0.0
PD-168393,Brc1cccc(Nc2ncnc3ccc(NC(=O)C=C)cc23)c1,0.0,0.0
bardoxolone-methyl,"COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2 |t:16,20|",0.0,0.0
rac-BHFF,"CC(C)(C)c1cc2c(OC(=O)[C@@]2(O)C(F)(F)F)c(c1)C(C)(C)C |&1:11,r|",0.0,0.0
sucralose,OC[C@H]1O[C@H](O[C@]2(CCl)O[C@H](CCl)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1Cl,0.0,0.0
prednisolone-hemisuccinate,"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCC(O)=O |a:1,3,15,20,&1:5,&2:6,&3:17,c:13,t:9|",0.0,0.0
felypressin,[H][C@@]1(Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O,0.0,0.0
ezutromid,CCN(CC)c1ccc(cc1)-n1nc2cc(C)c(N)cc2n1,0.0,0.0
"1,12-Besm",CCNCCCNCCCCNCCCNCC,0.0,0.0
cloperastine,Clc1ccc(cc1)[C@@H](OCCN1CCCCC1)c1ccccc1 |&1:7|,0.0,0.0
spautin-1,Fc1ccc(CNc2ncnc3ccc(F)cc23)cc1,0.0,0.0
tadalafil,CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3OCOc3c2)C1=O,0.0,0.0
AR-C155858,CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(C(=O)N3C[C@H](O)CO3)c2c(=O)n(C)c1=O,0.0,0.0
IBC-293,CC(C)n1nnc2cc(ccc12)C(O)=O,0.0,0.0
hexestrol,CC[C@@H]([C@@H](CC)c1ccc(O)cc1)c1ccc(O)cc1,0.0,0.0
tyrphostin-AG-835,C[C@H](NC(=O)C(=C\c1ccc(O)c(O)c1)\C#N)c1ccccc1,0.0,0.0
CK-101,OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F,0.0,0.0
dihomo-gamma-linolenic-acid,CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O,0.0,0.0
decernotinib,"CC[C@@](C)(Nc1ccnc(n1)-c1c[nH]c2ncccc12)C(=O)NCC(F)(F)F |&1:2,r|",0.0,0.0
PLX647,FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncccc34)cn2)cc1,0.0,0.0
SR-3306,Cc1ccc(cn1)-c1ncn(n1)-c1ccc(Nc2nccc(n2)-c2cccc(c2)N2CCOCC2)cc1,0.0,0.0
eribulin,"[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@@]7([H])O[C@@]8(C[C@@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2 |THB:43:44:51.53:48.49.56.58,50:49:44:51.53,50:51:44:48.49.56.58,53:54:46.48.49.58:41.43.59,59:56:44:51.53|",0.0,0.0
centhaquin,Cc1cccc(c1)N1CCN(CCc2ccc3ccccc3n2)CC1,0.0,0.0
trofinetide,NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O,0.0,0.0
corticosterone,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO |t:9|,0.0,0.0
tedizolid,Cn1nnc(n1)-c1ccc(cn1)-c1ccc(cc1F)N1C[C@H](CO)OC1=O,0.0,0.0
cefadroxil,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c1ccc(O)cc1)C2=O)C(O)=O |t:1|,0.0,0.0
diphencyprone,O=c1c(c1-c1ccccc1)-c1ccccc1,0.0,0.0
fomocaine,C(CN1CCOCC1)Cc1ccc(COc2ccccc2)cc1,0.0,0.0
glycopyrrolate,"C[N+]1(C)CC[C@@H](C1)OC(=O)[C@@](O)(C1CCCC1)c1ccccc1 |&1:5,&2:10|",0.0,0.0
paromomycin,NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O,0.0,0.0
PF-477736,Cn1cc(cn1)-c1[nH]c2cc(NC(=O)[C@H](N)C3CCCCC3)cc3c2c1cn[nH]c3=O,0.0,0.0
luliconazole,Clc1ccc([C@@H]2CS\C(S2)=C(\C#N)n2ccnc2)c(Cl)c1,0.0,0.0
DIM-C-pPhCO2Me,COC(=O)c1ccc(cc1)C(c1c[nH]c2ccccc12)c1c[nH]c2ccccc12,0.0,0.0
canagliflozin,Cc1ccc(cc1Cc1ccc(s1)-c1ccc(F)cc1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O,0.0,0.0
CGP-74514,CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc12,0.0,0.0
amisulpride,"CCN1CCC[C@@H]1CNC(=O)c1cc(c(N)cc1OC)S(=O)(=O)CC |&1:6,r|",0.0,0.0
bropirimine,Nc1nc(=O)c(Br)c([nH]1)-c1ccccc1,0.0,0.0
propoxur,CNC(=O)Oc1ccccc1OC(C)C,0.0,0.0
TCV-309,CCC[n+]1cc(Br)cc(c1)C(=O)N(CCC(=O)NCCOC(=O)N1CCc2ccccc2C1)c1ccccc1,0.0,0.0
quinine,COc1ccc2nccc([C@@H](O)[C@@H]3C[C@@H]4CC[N@]3C[C@@H]4C=C)c2c1,0.0,0.0
benzo[d]thiazole-2(3H)-thione,S=c1[nH]c2ccccc2s1,0.0,0.0
lersivirine,CCc1nn(CCO)c(CC)c1Oc1cc(cc(c1)C#N)C#N,0.0,0.0
MEK1-2-inhibitor,Nc1ccc(SC(=N)C(C#N)c2ccccc2C(F)(F)F)cc1,0.0,0.0
bafilomycin-a1,"[H][C@@]1(OC(=O)\C(OC)=C\C(\C)=C/[C@@H](C)[C@@H](O)[C@@H](C)C\C(C)=C\C=C\[C@@H]1OC)[C@@H](C)[C@@H](O)[C@H](C)[C@@]1(O)C[C@@H](O)[C@H](C)[C@H](O1)C(C)C |c:10,t:7,20,22|",0.0,0.0
acetylcholine,CC(=O)OCC[N+](C)(C)C,0.0,0.0
sodium-ascorbate,"OC[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@@H]1O |a:2,4,&1:8,&2:10|",0.0,0.0
pradefovir,Nc1ncnc2n(CCOC[P@@]3(=O)OCC[C@H](O3)c3cccc(Cl)c3)cnc12,0.0,0.0
vesnarinone,COc1ccc(cc1OC)C(=O)N1CCN(CC1)c1ccc2NC(=O)CCc2c1,0.0,0.0
MK-0608,C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1ccc2c(N)ncnc12,0.0,0.0
voreloxin,CN[C@H]1CN(C[C@@H]1OC)c1ccc2c(n1)n(cc(C(O)=O)c2=O)-c1nccs1,0.0,0.0
piperine,O=C(\C=C\C=C\c1ccc2OCOc2c1)N1CCCCC1,0.0,0.0
RG7800,CCc1nc(C)cn2nc(cc12)-c1cc(=O)n2cc(cc(C)c2n1)C1CCN(C)CC1,0.0,0.0
O-304,Clc1ccc(Cn2sc(NC(=O)c3ccc(Cl)cc3)nc2=O)cc1,0.0,0.0
2-APB,NCCOB(c1ccccc1)c1ccccc1,0.0,0.0
maraviroc,CC(C)c1nnc(C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,0.0,0.0
SQ-109,CC(C)=CCC\C(C)=C\CNCCNC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2 |r|,0.0,0.0
pindolol,"CC(C)NC[C@@H](O)COc1cccc2[nH]ccc12 |&1:5,r|",0.0,0.0
KN-62,"CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(CC1)c1ccccc1)S(=O)(=O)c1cccc2cnccc12 |&1:2,r|",0.0,0.0
benzocaine,CCOC(=O)c1ccc(N)cc1,0.0,0.0
lappaconite,CCN1C[C@@]2(CC[C@H](OC)[C@@]34[C@@H]5C[C@H]6[C@H](OC)[C@]5(O)[C@](O)(C[C@@H]6OC)[C@@H](C[C@H]23)[C@@H]14)OC(=O)c1ccccc1NC(C)=O,0.0,0.0
ostarine,C[C@](O)(COc1ccc(cc1)C#N)C(=O)Nc1ccc(C#N)c(c1)C(F)(F)F,0.0,0.0
S15535,C1C(Cc2ccccc12)N1CCN(CC1)c1cccc2OCCOc12,0.0,0.0
SB-203580,C[S@@](=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccc(F)cc1)-c1ccncc1 |&1:1|,0.0,0.0
Ro-04-5595,COc1cc2CCN(C)[C@@H](CCc3ccc(Cl)cc3)c2cc1O |&1:9|,0.0,0.0
oxyphenbutazone,CCCC[C@H]1C(=O)N(N(C1=O)c1ccc(O)cc1)c1ccccc1 |r|,0.0,0.0
NBI-74330-(+/-),"CCOc1ccc(cc1)-n1c(nc2ncccc2c1=O)[C@@H](C)N(Cc1cccnc1)C(=O)Cc1ccc(F)c(c1)C(F)(F)F |&1:20,r|",0.0,0.0
WAY-170523,Cc1cc(C)c(N(Cc2ccccc2)S(=O)(=O)c2ccc(OCCNC(=O)c3cc4ccccc4o3)cc2)c(c1)C(=O)NO,0.0,0.0
PF-05175157,[H]n1c(C)nc2ccc(cc12)C(=O)N1CCC2(CC1)Cc1cnn(C(C)C)c1C(=O)C2,0.0,0.0
acoziborole,CC1(C)OB(O)c2cc(NC(=O)c3ccc(F)cc3C(F)(F)F)ccc12,0.0,0.0
frentizole,COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1,0.0,0.0
REV-5901,"CCCCC[C@@H](O)c1cccc(OCc2ccc3ccccc3n2)c1 |&1:5,r|",0.0,0.0
MK-0557,Fc1ccccc1-n1ccc(NC(=O)[C@H]2CC[C@]3(CC2)OC(=O)c2ccncc32)n1 |r|,0.0,0.0
OXA-06,Fc1ccccc1CNCc1ccc(cc1)-c1ccnc2[nH]ccc12,0.0,0.0
urethane,CCOC(N)=O,0.0,0.0
gabazine,COc1ccc(cc1)-c1ccc(=N)n(CCCC(O)=O)n1,0.0,0.0
BL-5583,OC(=O)c1cc2ccccc2s1,0.0,0.0
roquinimex,CN(C(=O)c1c(O)c2ccccc2n(C)c1=O)c1ccccc1,0.0,0.0
omeprazole-sulfide,COc1ccc2nc(SCc3ncc(C)c(OC)c3C)[nH]c2c1,0.0,0.0
pirmenol,"C[C@H]1CCC[C@@H](C)N1CCC[C@@](O)(c1ccccc1)c1ccccn1 |a:1,5,&1:11|",0.0,0.0
teicoplanin-A2-3,CC(C)CCCCCCCC(=O)N[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1Oc1c2Oc3ccc(C[C@H]4NC(=O)[C@H](N)c5ccc(O)c(Oc6cc(O)cc(c6)[C@H](NC4=O)C(=O)N[C@H]4c(c2)cc1Oc1ccc(cc1Cl)[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1NC(C)=O)[C@@H]1NC(=O)[C@@H](NC4=O)c2ccc(O)c(c2)-c2c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)cc(O)cc2[C@@H](NC1=O)C(O)=O)c5)cc3Cl,0.0,0.0
AK-7,Brc1cccc(NC(=O)c2cccc(c2)S(=O)(=O)N2CCCCCC2)c1,0.0,0.0
SKF-38393,Oc1cc2CCNC[C@@H](c3ccccc3)c2cc1O |&1:8|,0.0,0.0
doconexent-ethyl-ester,CCOC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,0.0,0.0
azelaic-acid,OC(=O)CCCCCCCC(O)=O,0.0,0.0
propylthiouracil,CCCc1cc(=O)[nH]c(=S)[nH]1,0.0,0.0
ipragliflozin-L-proline,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(F)c(Cc2cc3ccccc3s2)c1,0.0,0.0
AC-261066,CCCCOCCOc1nc(sc1C)-c1ccc(C(O)=O)c(F)c1,0.0,0.0
8-M-PDOT,"CCC(=O)N[C@H]1CCc2cccc(OC)c2C1 |&1:5,r|",0.0,0.0
lauric-acid,CCCCCCCCCCCC(O)=O,0.0,0.0
ceramide,CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO)NC(C)=O,0.0,0.0
dicycloverine,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,0.0,0.0
GW-7647,CC(C)(Sc1ccc(CCN(CCCCC2CCCCC2)C(=O)NC2CCCCC2)cc1)C(O)=O,0.0,0.0
naxagolide,CCCN1CCO[C@H]2[C@H]1CCc1ccc(O)cc21,0.0,0.0
GSK-LSD-1,C1[C@@H](NC2CCNCC2)[C@@H]1c1ccccc1,0.0,0.0
PF-03882845,OC(=O)c1ccc2C3=NN([C@@H](C4CCCC4)C3CCc2c1)c1ccc(C#N)c(Cl)c1 |t:7|,0.0,0.0
levocarnitine,C[N+](C)(C)C[C@H](O)CC(O)=O,0.0,0.0
dopamine,NCCc1ccc(O)c(O)c1,0.0,0.0
TEN-010,CN1CCN(CCCNC(=O)C[C@@H]2N=C(c3c(C)c(C)sc3-n3c(C)nnc23)c2ccc(Cl)cc2)CC1 |c:13|,0.0,0.0
cresol,Cc1ccc(O)cc1,0.0,0.0
revefenacin,CN(CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1)C(=O)c1ccc(CN2CCC(CC2)C(N)=O)cc1,0.0,0.0
L-NAME,COC(=O)[C@@H](N)CCCNC(N)=N[N+]([O-])=O,0.0,0.0
cyclizine,CN1CCN(CC1)C(c1ccccc1)c1ccccc1,0.0,0.0
diquafosol,O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n2ccc(=O)[nH]c2=O)O[C@H]([C@@H]1O)n1ccc(=O)[nH]c1=O,0.0,0.0
ONO-8130,CC(C)CN(c1cc2CCCc2cc1OCc1ccc(cc1)C(O)=O)S(=O)(=O)c1nc(C)cs1,0.0,0.0
alagebrium,Cc1sc[n+](CC(=O)c2ccccc2)c1C,0.0,0.0
TAK-901,CCS(=O)(=O)c1cccc(c1)-c1cc(C(=O)NC2CCN(C)CC2)c(C)c2[nH]c3ncc(C)cc3c12,0.0,0.0
albendazole,CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1,0.0,0.0
bevirimat-dimeglumine,CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(O)=O,0.0,0.0
SP-100030,FC(F)(F)c1cc(NC(=O)c2cnc(Cl)nc2C(F)(F)F)cc(c1)C(F)(F)F,0.0,0.0
OAC2,O=C(Nc1ccc2[nH]ccc2c1)c1ccccc1,0.0,0.0
indatraline,CN[C@@H]1C[C@H](c2ccccc12)c1ccc(Cl)c(Cl)c1,0.0,0.0
gepon,"CC(C)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](N)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O |a:3,11,20,51,69,80,100,118,&1:7,&2:31,&3:42,&4:60,&5:71,&6:74,&7:89,&8:109|",0.0,0.0
WAY-207024,CC(C)(C)c1ccc(cc1)-c1nc2c(cccc2[nH]1)N1CCN(Cc2ccc3nccnc3c2)CC1,0.0,0.0
silodosin,C[C@H](Cc1cc2CCN(CCCO)c2c(c1)C(N)=O)NCCOc1ccccc1OCC(F)(F)F,0.0,0.0
S-3304,Cc1ccc(cc1)C#Cc1ccc(s1)S(=O)(=O)N[C@H](Cc1c[nH]c2ccccc12)C(O)=O,0.0,0.0
TGX-221,"C[C@@H](Nc1ccccc1)c1cc(C)cn2c1nc(cc2=O)N1CCOCC1 |&1:1,r|",0.0,0.0
CP-724714,COCC(=O)NC\C=C\c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,0.0,0.0
endoxifen,CC\C(=C(/c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1,0.0,0.0
selexipag,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(n1)-c1ccccc1,0.0,0.0
diarylpropionitrile,"Oc1ccc(C[C@@H](C#N)c2ccc(O)cc2)cc1 |&1:6,r|",0.0,0.0
kasugamycin,C[C@H]1O[C@H](O[C@@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]2O)[C@@H](N)C[C@@H]1NC(=N)C(O)=O,0.0,0.0
noretynodrel,"C[C@]12CC[C@H]3[C@@H](CCC4=C3CCC(=O)C4)[C@@H]1CC[C@@]2(O)C#C |a:1,18,&1:4,&2:5,&3:15,c:8|",0.0,0.0
salicylamide,NC(=O)c1ccccc1O,0.0,0.0
lithium-acetoacetate,CC(=O)CC(O)=O,0.0,0.0
moexipril,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(O)=O,0.0,0.0
PSI-6130,C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O,0.0,0.0
GS-9973,C1CN(CCO1)c1ccc(Nc2nc(cn3ccnc23)-c2ccc3c[nH]nc3c2)cc1,0.0,0.0
dinoprost,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O,0.0,0.0
trabodenoson,O[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@H]([C@@H]1O)n1cnc2c(NC3CCCC3)ncnc12,0.0,0.0
isometheptene-mucate,"CN[C@@H](C)CCC=C(C)C |&1:2,r|",0.0,0.0
isoflurane,"FC(F)O[C@@H](Cl)C(F)(F)F |&1:4,r|",0.0,0.0
CR8-(R),CC[C@H](CO)Nc1nc(NCc2ccc(cc2)-c2ccccn2)c2ncn(C(C)C)c2n1,0.0,0.0
escin,CC=C(C)C(=O)O[C@H]1[C@H](OC(C)=O)[C@]2(CO)[C@H](O)C[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@@H]([C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)C(O)=O)[C@](C)(CO)[C@@H]5CC[C@@]34C)[C@@H]2CC1(C)C |c:21|,0.0,0.0
metergoline,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@H]2[C@H]1Cc1cn(C)c3cccc2c13,0.0,0.0
FG-4592,Cc1nc(C(=O)NCC(O)=O)c(O)c2ccc(Oc3ccccc3)cc12,0.0,0.0
PTC-209,COc1cc(Br)c(Nc2nc(cs2)-c2c(C)nc3ncccn23)c(Br)c1,0.0,0.0
PI3Kd-IN-2,COc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)C(C)(C)O)cc(F)cc12)N1CCOCC1,0.0,0.0
CCT245737,FC(F)(F)c1cnc(Nc2cnc(cn2)C#N)cc1NC[C@H]1CNCCO1,0.0,0.0
pelitinib,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)\C=C\CN(C)C,0.0,0.0
salirasib,CC(C)=CCC\C(C)=C\CC\C(C)=C\CSc1ccccc1C(O)=O,0.0,0.0
PCA-4248,"COC(=O)C1=C(C)NC(C)=C([C@@H]1C)C(=O)OCCSc1ccccc1 |&1:11,r,c:4,9|",0.0,0.0
eletriptan,CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12,0.0,0.0
tinidazole,CCS(=O)(=O)CCn1c(C)ncc1[N+]([O-])=O,0.0,0.0
melphalan-n-oxide,N[C@@H](Cc1ccc(cc1)[N+]([O-])(CCCl)CCCl)C(O)=O,0.0,0.0
PG-9,"C[C@@H](C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C)c1ccc(Br)cc1 |&1:5,7,10,&2:1,r,TLB:13:12:8.9:5.6.11|",0.0,0.0
PD-168077,Cc1cccc(c1)C(=O)NCN1CCN(CC1)c1ccccc1C#N,0.0,0.0
PNU-282987,Clc1ccc(cc1)C(=O)N[C@H]1CN2CCC1CC2,0.0,0.0
CGP-53353,Fc1ccc(Nc2cc3C(=O)NC(=O)c3cc2Nc2ccc(F)cc2)cc1,0.0,0.0
nonoxynol-9,CCCCCCCCCc1ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)cc1,0.0,0.0
levothyroxine,N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(O)=O,0.0,0.0
"5-amino-3-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione",Nc1nc(=O)c2sc(=O)n([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2[nH]1,0.0,0.0
rolziracetam,O=C1CCC2CCC(=O)N12,0.0,0.0
yoda-1,Clc1cccc(Cl)c1CSc1nnc(s1)-c1cnccn1,0.0,0.0
CYM-5442,CCOc1ccc(cc1OCC)-c1nc(no1)-c1cccc2[C@@H](CCc12)NCCO |&1:22|,0.0,0.0
maltobionic-acid,OC[C@@H](O)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)C(O)=O,0.0,0.0
Ro-08-2750,Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C)c2cc1C=O,0.0,0.0
vitamin-E,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(C)c(O)c(C)c(C)c2O1,0.0,0.0
benzoylpas,OC(=O)c1ccc(NC(=O)c2ccccc2)cc1O,0.0,0.0
OTX015,Cc1sc-2c(c1C)C(=N[C@@H](CC(=O)Nc1ccc(O)cc1)c1nnc(C)n-21)c1ccc(Cl)cc1 |c:8|,0.0,0.0
AMG-PERK-44,Cc1ccc2cc(ccc2n1)-c1c(C)ccc(C(=O)c2c(-c3ccccc3)n(C)n(-c3ccccc3)c2=O)c1N,0.0,0.0
aspartame,COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(O)=O,0.0,0.0
necrostatin-2,CN1C(=O)N[C@H](Cc2c[nH]c3c(Cl)cccc23)C1=O,0.0,0.0
mefloquine,O[C@H]([C@H]1CCCCN1)c1cc(nc2c(cccc12)C(F)(F)F)C(F)(F)F,0.0,0.0
NXY-059,CC(C)(C)[N+](\[O-])=C\c1ccc(cc1S(O)(=O)=O)S(O)(=O)=O,0.0,0.0
adavivint,CC(C)CC(=O)Nc1cncc(c1)-c1ccc2[nH]nc(-c3nc4cncc(-c5cccc(F)c5)c4[nH]3)c2c1,0.0,0.0
azaguanine-8,Nc1nc2nn[nH]c2c(=O)[nH]1,0.0,0.0
clobetasone-butyrate,"CCCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)C(=O)C[C@]12C)C(=O)CCl |c:18,t:14|",0.0,0.0
BETP,"CC[S@](=O)c1nc(cc(n1)C(F)(F)F)-c1cccc(OCc2ccccc2)c1 |&1:2,r|",0.0,0.0
MK-3697,COc1ccc(CNC(=O)c2cc(ncc2-c2nccs2)-c2cncc(C)c2)nc1OC,0.0,0.0
mirtazapine,"CN1CCN2[C@@H](C1)c1ccccc1Cc1cccnc21 |&1:5,r|",0.0,0.0
D-serine,N[C@H](CO)C(O)=O,0.0,0.0
ACPC,NC1(CC1)C(O)=O,0.0,0.0
cibenzoline,"C1[C@@H](C2=NCCN2)C1(c1ccccc1)c1ccccc1 |r,t:2|",0.0,0.0
LTB4,CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O,0.0,0.0
letosteine,"CCOC(=O)CSCC[C@H]1N[C@@H](CS1)C(O)=O |&1:9,&2:11,r|",0.0,0.0
K145,CCCCOc1ccc(CC\C=C2/SC(=O)N(CCN)C2=O)cc1,0.0,0.0
doramectin,"[H][C@@]12OC\C3=C/C=C/[C@H](C)[C@H](O[C@@]4([H])C[C@H](OC)[C@@H](O[C@@]5([H])C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)\C(C)=C\C[C@]4([H])C[C@@]([H])(C[C@@]5(O[C@H](C6CCCCC6)[C@@H](C)C=C5)O4)OC(=O)[C@]([H])(C=C(C)[C@H]1O)[C@@]23O |c:4,58,t:6,37,68|",0.0,0.0
vatinoxan,[H][C@@]12C[C@@]3(CNC(=O)N3CCNS(C)(=O)=O)CCN1CCc1c2oc2ccccc12,0.0,0.0
benzoin,"O[C@@H](C(=O)c1ccccc1)c1ccccc1 |&1:1,r|",0.0,0.0
GW-0742,Cc1nc(sc1CSc1ccc(OCC(O)=O)c(C)c1)-c1ccc(c(F)c1)C(F)(F)F,0.0,0.0
glyburide,COc1ccc(Cl)cc1C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1,0.0,0.0
OT-R-antagonist-1,CO\N=C1\C[C@H](N(C1)C(=O)c1ccc(cc1)-c1ccccc1C)C(=O)NC[C@@H](O)c1ccccc1,0.0,0.0
captamine,CN(C)CCS,0.0,0.0
telaprevir,CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1,0.0,0.0
DMAB-anabaseine,CN(C)c1ccc(\C=C2/CCCN=C2c2cccnc2)cc1 |c:12|,0.0,0.0
DWK-1339,COCCCc1ccc2oc(cc2c1)-c1ccc(OC)c(OC)c1,0.0,0.0
thiostrepton,"CC[C@H](C)[C@@H]1N[C@@H]2C=Cc3c(cc(nc3[C@H]2O)C(=O)O[C@H](C)[C@@H]2NC(=O)c3csc(n3)[C@@H](NC(=O)[C@H]3CSC(=N3)\C(NC(=O)[C@@H](NC(=O)c3csc(n3)[C@]3(CCC(=N[C@@H]3c3csc2n3)c2nc(cs2)C(=O)NC(=C)C(=O)NC(=C)C(N)=O)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)=C\C)[C@](C)(O)[C@@H](C)O)[C@H](C)O |c:7,41,61|",0.0,0.0
pirquinozol,OCc1cc2c3ccccc3[nH]c(=O)n2n1,0.0,0.0
levonorgestrel,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C |t:9|,0.0,0.0
ansamitocin-p-3,"[H][C@@]12O[C@@]1(C)[C@H](CC(=O)N(C)c1cc(C\C(C)=C\C=C\[C@@H](OC)[C@@]3(O)C[C@]([H])(OC(=O)N3)[C@H]2C)cc(OC)c1Cl)OC(=O)C(C)C |t:17,19|",0.0,0.0
alclometasone-dipropionate,"CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@H]2[C@H]3[C@H](Cl)CC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C |a:14,17,19,28,30,31,34,&1:8,&2:18,c:26,t:22|",0.0,0.0
JNJ-42041935,OC(=O)c1cnn(c1)-c1nc2cc(Cl)c(OC(F)(F)F)cc2[nH]1,0.0,0.0
ZM-336372,CN(C)c1cccc(c1)C(=O)Nc1ccc(C)c(NC(=O)c2ccc(O)cc2)c1,0.0,0.0
presatovir,Cc1cn2nc(cc2nc1N1CC[C@H](N)C1)[C@@H]1CCCCN1C(=O)c1cc(Cl)ccc1NS(C)(=O)=O,0.0,0.0
SR-3677,CN(C)CCOc1cc(ccc1NC(=O)[C@H]1COc2ccccc2O1)-c1cn[nH]c1 |&1:15|,0.0,0.0
etoxybamide,OCCCC(=O)NCCO,0.0,0.0
PETCM,"O[C@@H](Cc1ccncc1)C(Cl)(Cl)Cl |&1:1,r|",0.0,0.0
bergenin,COc1c(O)cc2C(=O)O[C@@H]3[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]3c2c1O,0.0,0.0
letrazuril,"Fc1ccc(cc1)[C@@H](C#N)c1c(Cl)cc(cc1Cl)-n1ncc(=O)[nH]c1=O |&1:7,r|",0.0,0.0
avacopan,Cc1ccc(NC(=O)[C@H]2CCCN([C@H]2c2ccc(NC3CCCC3)cc2)C(=O)c2c(C)cccc2F)cc1C(F)(F)F,0.0,0.0
aripiprazole-lauroxil,CCCCCCCCCCCC(=O)OCN1C(=O)CCc2ccc(OCCCCN3CCN(CC3)c3cccc(Cl)c3Cl)cc12,0.0,0.0
ML213,"Cc1cc(C)c(NC(=O)[C@@H]2C[C@H]3CC[C@@H]2C3)c(C)c1 |&1:11,14,&2:9,r|",0.0,0.0
trichloroacetic-acid,OC(=O)C(Cl)(Cl)Cl,0.0,0.0
U-18666A,CCN(CC)CCO[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CCC4=O)[C@@H]3CC=C2C1 |c:27|,0.0,0.0
merbromin,O[Hg]c1c(O)c(Br)cc2c(-c3ccccc3C(O)=O)c3cc(Br)c(=O)cc3oc12,0.0,0.0
glecaprevir,[H]\C1=C([H])/C(F)(F)c2nc3ccccc3nc2O[C@@]2([H])CN(C(=O)[C@@]([H])(NC(=O)O[C@]3([H])CCC[C@@]3([H])OC1)C(C)(C)C)[C@@]([H])(C2)C(=O)N[C@@]1(C[C@@]1([H])C(F)F)C(=O)NS(=O)(=O)C1(C)CC1 |t:1|,0.0,0.0
SN-2,"Cc1cc(C)c(C2=NO[C@@H]3[C@H]4CC[C@H](C4)[C@H]23)c(C)c1 |&1:9,10,13,15,t:6|",0.0,0.0
securinine,"O=C1O[C@@]23C[C@@H](C=CC2=C1)N1CCCC[C@H]31 |c:6,9|",0.0,0.0
4-aminohippuric-acid,Nc1ccc(cc1)C(=O)NCC(O)=O,0.0,0.0
almorexant,CNC(=O)[C@H](N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(cc1)C(F)(F)F)c1ccccc1,0.0,0.0
fenclonine-(+/-),N[C@@H](Cc1ccc(Cl)cc1)C(O)=O |&1:1|,0.0,0.0
tolterodine,CC(C)N(CC[C@H](c1ccccc1)c1cc(C)ccc1O)C(C)C,0.0,0.0
atosiban,"CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@@H](C)CC)[C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)cc1 |a:8,17,21,33,37,41,50,54,&1:29|",0.0,0.0
pyrvinium-pamoate,CN(C)c1ccc2[n+](C)c(\C=C\c3cc(C)n(c3C)-c3ccccc3)ccc2c1,0.0,0.0
degarelix,CC(C)C[C@H](NC(=O)[C@@H](Cc1ccc(NC(N)=O)cc1)NC(=O)[C@H](Cc1ccc(NC(=O)[C@@H]2CC(=O)NC(=O)N2)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,0.0,0.0
CP-673451,COCCOc1ccc2n(cnc2c1)-c1ccc2cccc(N3CCC(N)CC3)c2n1,0.0,0.0
PF-573228,CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4NC(=O)CCc4c3)ncc2C(F)(F)F)c1,0.0,0.0
oxotremorine-sesquifumarate,O=C1CCCN1CC#CCN1CCCC1,0.0,0.0
emiglitate,CCOC(=O)c1ccc(OCCN2C[C@H](O)[C@@H](O)[C@H](O)[C@H]2CO)cc1,0.0,0.0
BMS-986142,Cc1c(cccc1-n1c(=O)n(C)c2c(F)cccc2c1=O)-c1c(F)cc(C(N)=O)c2[nH]c3C[C@H](CCc3c12)C(C)(C)O,0.0,0.0
primaquine,COc1cc(N[C@@H](C)CCCN)c2ncccc2c1 |r|,0.0,0.0
coumarin,O=c1ccc2ccccc2o1,0.0,0.0
genipin,"COC(=O)C1=CO[C@@H](O)[C@H]2[C@@H]1CC=C2CO |c:13,t:4|",0.0,0.0
A-784168,FC(F)(F)c1cccnc1N1CCC(=CC1)C(=O)Nc1ccc(cc1)S(=O)(=O)C(F)(F)F |c:14|,0.0,0.0
N-oxydiethylenebenzothiazole-2-sulfenamide,C1CN(CCO1)Sc1nc2ccccc2s1,0.0,0.0
radafaxine,C[C@@H]1NC(C)(C)CO[C@@]1(O)c1cccc(Cl)c1,0.0,0.0
GANT-61,CN(C)c1ccccc1CN1CCCN(Cc2ccccc2N(C)C)C1c1ccncc1,0.0,0.0
khellin,COc1c2ccoc2c(OC)c2oc(C)cc(=O)c12,0.0,0.0
fedratinib,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C,0.0,0.0
TP-0903,CN(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(CN3CCN(C)CC3)cc2)ncc1Cl,0.0,0.0
cariprazine,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2cccc(Cl)c2Cl)CC1 |r|,0.0,0.0
furamidine,NC(=N)c1ccc(cc1)-c1ccc(o1)-c1ccc(cc1)C(N)=N,0.0,0.0
PK-THPP,CCCC(=O)C1CCN(CC1)c1ncnc2CCN(Cc12)C(=O)c1ccc(cc1)-c1ccccc1,0.0,0.0
tetrandrine,COc1ccc2C[C@@H]3N(C)CCc4cc(OC)c(OC)c(Oc5cc6[C@H](Cc7ccc(Oc1c2)cc7)N(C)CCc6cc5OC)c34,0.0,0.0
tozasertib,CN1CCN(CC1)c1cc(Nc2cc(C)n[nH]2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,0.0,0.0
dexniguldipine,"COC(=O)C1=C(C)NC(C)=C([C@@H]1c1cccc(c1)[N+]([O-])=O)C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1 |c:4,9|",0.0,0.0
CP-93129,O=c1ccc2[nH]cc(C3=CCNCC3)c2[nH]1 |t:8|,0.0,0.0
ribostamycin,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O,0.0,0.0
